WO2024027717A1 - Total system and method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microsphere - Google Patents

Total system and method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microsphere Download PDF

Info

Publication number
WO2024027717A1
WO2024027717A1 PCT/CN2023/110588 CN2023110588W WO2024027717A1 WO 2024027717 A1 WO2024027717 A1 WO 2024027717A1 CN 2023110588 W CN2023110588 W CN 2023110588W WO 2024027717 A1 WO2024027717 A1 WO 2024027717A1
Authority
WO
WIPO (PCT)
Prior art keywords
microsphere
fluid
flow channel
sorting
storage device
Prior art date
Application number
PCT/CN2023/110588
Other languages
French (fr)
Chinese (zh)
Inventor
田甜
富国祥
Original Assignee
丹望医疗科技(上海)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 丹望医疗科技(上海)有限公司 filed Critical 丹望医疗科技(上海)有限公司
Publication of WO2024027717A1 publication Critical patent/WO2024027717A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/16Microfluidic devices; Capillary tubes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/46Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/48Automatic or computerized control
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/04Cell isolation or sorting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0679Cells of the gastro-intestinal tract
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0647Handling flowable solids, e.g. microscopic beads, cells, particles
    • B01L2200/0652Sorting or classification of particles or molecules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept

Definitions

  • the present disclosure relates to the field of in vitro organ technology. Specifically, the present disclosure relates to a total system and method for fully automated in vitro organ microsphere preparation, sorting, and distribution culture.
  • Organoids are multicellular structures with a three-dimensional structure that are functionally close to organs, formed from embryonic stem cells, pluripotent stem cells or adult somatic cells under a certain culture environment and the support of extracellular matrix. Compared with cell line culture, organoids have a three-dimensional microstructure that is closer to the state of in vivo tissues. They can retain tumor heterogeneity in tumor models and have wide application in many fields such as drug screening, pathological research, and precision medicine. potential.
  • the traditional organoid culture method mainly uses Matrigel as the supporting matrix. The organoid seeds are mixed with Matrigel and then inoculated into the culture dish through a pipette.
  • the Matrigel is solidified at 37°C to achieve the effect of three-dimensional culture.
  • the size of the organoids cultured by this method and the number of organoid microspheres formed in the culture dish are uncontrollable, and the entire process is manual operation, which has low efficiency.
  • the culture state of the organoids is greatly affected by the differences between operators and cannot be controlled. It is conducive to the standardization and throughput culture of organoids, but it also cannot meet the needs of drug screening.
  • Ultra-low adhesion U-shaped well plates are also used for organoid culture. This method modifies the surface material of the well plate so that cells will not grow adherently on its surface, and then uses the bottom of the prototype well to allow cells to grow due to gravity.
  • Patent CN110004111B discloses a method for preparing organoid spheroids. This method uses a syringe pump and a three-way device to prepare organoid droplet microspheres.
  • the oil phase is fluorine oil
  • the water phase is a mixture of matrigel and cells. Inject the water phase and oil phase into a syringe respectively.
  • the syringe is connected to the tee device and a syringe pump is used to drive the syringe.
  • the syringe pump is placed in the refrigerator (4°C) to maintain the matrigel.
  • Patent CN110042077B discloses a high-throughput culture method for organoid spheroids. This method is a continuation of the previous patent. The above-mentioned patent is used to obtain organoid microspheres, then heated, and linked with the 3D printing platform to convert the organoid spheroids. Make allocations.
  • the disadvantages of the above two patented technologies are: 1. The entire system is simply built with multiple instruments (such as refrigerators), which is large in size, troublesome to operate, and is not conducive to promotion; 2. The system cannot be placed in a biological safety cabinet for operation. A sterile environment cannot be guaranteed, and the prepared organoids may have the risk of contamination; 3. The system lacks a real-time observation module and cannot realize observation and quality monitoring functions; 4. The system lacks an automatic liquid addition function and it is difficult to achieve high-pass performance in the true sense. The survival rate of organoids is not guaranteed due to high-volume culture; 5. Since syringe pumps and syringes are involved, the replacement and addition of oil and water phase samples are cumbersome and there are interfering factors such as bubbles; 6. The organoids are distributed using a 3D printing platform. During the movement, it is easy to cause disturbance of the organoids in the tubing, thereby affecting the accuracy of distribution.
  • one object of the present disclosure is to provide a fully automated overall system and method for in vitro organ microsphere preparation, sorting, and distribution culture.
  • the modular system constructed by this disclosure can realize nowadays, the automated preparation, detection, sorting, and distribution of hair fluid for culture of VOS are simple to operate and pollution-free. It provides a reproducible in vitro biological model for drug screening and efficacy evaluation, and has good application prospects and promotion value.
  • the present disclosure provides a fully automated total system for in vitro organ microsphere preparation, sorting, and distribution culture.
  • the total system for fully automated in vitro organ microsphere preparation, sorting and distribution culture includes:
  • the preparation system is used to prepare in vitro organ microspheres, the preparation system includes a microsphere preparation flow channel provided on a microfluidic chip, the microsphere preparation flow channel includes a microsphere fluid flow channel;
  • the detection and sorting system includes a defective microsphere fluid channel and a qualified microsphere fluid channel formed by the bifurcation of the microsphere fluid channel, the defective microsphere fluid channel and the qualified microsphere fluid channel
  • the microsphere fluid channels are all arranged on the microfluidic chip.
  • the microsphere fluid channels are provided with asymmetric electrodes on the corresponding microfluidic chip before bifurcation, and one side of the defective microsphere fluid channel The electric field generated by the corresponding electrode is greater than the electric field generated by the corresponding electrode on one side of the qualified microsphere fluid channel.
  • the detection and sorting system also includes a signal generator, a detection and sorting control unit and an optical detection unit.
  • the optical detection unit is arranged above the microfluidic chip corresponding to the microsphere fluid channel before bifurcation, and the signal generator is connected to the asymmetric electrode and the detection and sorting control unit respectively, and the detection and sorting control unit The control unit is connected to the optical detection unit and the signal generator respectively;
  • the hair liquid distributing system is used for distributing the qualified microsphere fluid sorted by the detection and sorting system into the orifice plate and adding the qualified microsphere fluid packed in the orifice plate. Culture fluid.
  • the modular system constructed by the present disclosure can realize the automated preparation, detection, sorting, and distribution of hair fluid culture of VOS, and is simple to operate and It is pollution-free, provides a reproducible in vitro biological model for drug screening and efficacy evaluation, and has good application prospects and promotion value.
  • the detection and sorting function is integrated on the chip to screen VOS with more dead cells or no cells to ensure that all VOS obtained are highly active and achieve effective sorting of target VOS.
  • the total system for fully automated in vitro organ microsphere preparation, sorting, and distribution culture may also have the following additional technical features:
  • the microsphere preparation flow channel includes: a cell fluid flow channel of a shell structure, a cell fluid flow channel of a core structure, and an oil phase flow channel.
  • the cell fluid flow channel of the shell structure and the core structure are The cell fluid flow channels of the structure merge to form a merged flow channel, and the merged flow channel merges with the oil phase flow channel to form a microsphere fluid flow channel.
  • the cell fluid flow channels of the shell structure are arranged on both sides of the cell fluid flow channels of the core structure.
  • the The oil phase flow channel is arranged on both sides of the converging flow channel.
  • the preparation system further includes: a first liquid storage device, the liquid outlet of the first liquid storage device is connected to the inlet of the cell fluid flow channel of the shell structure, the first liquid storage device The fluid device is used to store cellular fluids in the shell structure;
  • the liquid outlet of the second liquid storage device is connected to the inlet of the cell fluid flow channel of the nuclear structure, and the second liquid storage device is used to store the cell fluid of the nuclear structure;
  • a third liquid storage device the liquid outlet of the third liquid storage device is connected to the inlet of the oil phase flow channel, and the third liquid storage device is used to store the oil phase;
  • a pressure controller and a diaphragm pump is connected to the first liquid storage device, the second liquid storage device and the third liquid storage device respectively.
  • the diaphragm pump is connected to the pressure controller. .
  • the preparation system further includes: a flow rate control unit connected to the pressure controller.
  • the preparation system further includes: a refrigeration module, the refrigeration module is used to combine the microfluidic chip, the first liquid storage device, the second liquid storage device and the third liquid storage device.
  • the temperature of the three liquid storage devices is maintained at a certain set temperature.
  • the preparation system further includes: a heat preservation unit, the microfluidic chip, the first liquid storage device, the second liquid storage device and the third liquid storage device are all arranged in inside the insulation unit.
  • the width of the cell fluid flow channel of the shell structure is 100-150 ⁇ m, and the flow rate of the cell fluid of the shell structure in the cell fluid flow channel of the shell structure is 0.5-5 ⁇ L/min.
  • the width of the cellular fluid channel of the nuclear structure is 100-150 ⁇ m
  • the flow rate of the cellular fluid of the nuclear structure in the cellular fluid channel of the nuclear structure is 0.5-5 ⁇ L/min.
  • the width of the oil phase flow channel is 75-300 ⁇ m, and the flow rate of the oil phase in the oil phase flow channel is 1-20 ⁇ L/min.
  • the cellular fluid of the shell structure within the cellular fluid channel of the shell structure includes cells of the shell structure and the first hydrogel
  • the cellular fluid of the core structure within the cellular fluid channel of the core structure includes The cells of the core structure and the second hydrogel
  • the cells of the shell structure are different from the cells of the core structure
  • the first hydrogel and the second hydrogel are different
  • the cells of the shell structure are selected From at least one of umbilical cord vein endothelial cells and immune cells
  • the cells of the nuclear structure are selected from at least one of tumor cells and stem cells
  • the first hydrogel is selected from the group consisting of fibrinogen, collagen and alginate
  • At least one of the second hydrogel is selected from at least one of Matrigel, fibrinogen and collagen.
  • the microsphere preparation flow channel includes: a cell fluid flow channel and an oil phase flow channel, and the cell fluid flow channel and the oil phase flow channel merge to form a microsphere fluid flow channel.
  • the total system further includes a heating unit for forming the qualified microspheres into a solid state, and one end of the heating unit is connected to the outlet of the qualified microsphere fluid flow channel;
  • the hair liquid dispensing system includes:
  • the mobile unit includes a mobile platform, an X-direction slide rail and a Y-direction slide rail.
  • the Y-direction slide rail is vertically arranged on the slide rail.
  • the Y-direction slide rail can move along the Y-direction on the slide rail. move, the X-direction slide rail is vertically arranged on the Y-direction slide rail, the X-direction slide rail can move along the X-direction on the Y-direction slide rail, and the mobile platform is fixed on the X-direction slide rail. above the rail;
  • a well plate is arranged on the mobile platform, and the well plate is provided with a plurality of culture wells;
  • the microsphere fluid distribution unit includes a microsphere fluid distribution tube, a first connecting rod and a first vertical rod, the first vertical rod is arranged on the support plate, the microsphere fluid distribution unit The pipe is supported above the culture hole through a first connecting rod.
  • the microsphere fluid distribution tube includes a distribution head. The distribution head is provided at the lower end of the microsphere fluid distribution tube.
  • the microsphere fluid distribution tube has The upper end is connected to the other end of the heating unit;
  • Culture liquid pipetting unit the culture liquid pipetting unit includes the culture liquid pipette, a second connecting rod and a second vertical rod, the second vertical rod is arranged on the support plate, the culture liquid pipetting unit The pipette is supported above the culture hole through a second connecting rod, and a plurality of pipette tips are provided at the bottom of the culture liquid pipette.
  • the hair liquid dispensing system further includes: a hair liquid distributing control unit, which is respectively connected to the moving unit, the microsphere fluid dispensing unit and the culture liquid pipetting unit. units are connected.
  • the first connecting rod is configured to rotate circumferentially about the axis of the first vertical rod, the first vertical rod is configured to be telescopic up and down, and the second vertical rod is configured to be able to move up and down. Telescopic.
  • Another aspect of the present disclosure provides a method for in vitro organ microsphere preparation, sorting, and distribution culture using the overall system described in the above embodiments. According to an embodiment of the present disclosure, the method includes:
  • in vitro organ microspheres are prepared in the microsphere preparation flow channel, and the in vitro organ microspheres are wrapped in an oil phase to form a pre-sorting microsphere fluid;
  • an optical detection unit is used to observe the pre-sorting microspheres, and the optical detection unit sends the observation results to the detection and sorting control unit. If the sorting If there is a defect in the front microsphere, the detection and sorting control unit sends an instruction to the signal generator, and the signal generator turns on the asymmetric electrode to generate an uneven electric field. The uneven electric field causes the defective microsphere to deviate. Enter the defective microsphere fluid flow channel;
  • the asymmetric electrode is not connected so that qualified microspheres enter the qualified microsphere fluid flow channel;
  • the fully automated in vitro organ microsphere preparation, sorting and distribution culture method according to the embodiments of the present disclosure has all the advantages of the fully automated in vitro organ microsphere preparation, sorting and distribution culture system described in the above embodiments. This will not be described again.
  • Figure 1 shows a schematic diagram of the overall system for fully automated in vitro organ microsphere preparation, sorting and distribution culture according to an embodiment of the present disclosure
  • Figure 2 shows a schematic structural diagram of a microfluidic chip according to an embodiment of the present disclosure
  • Figure 3 shows a schematic structural diagram of a preparation system according to an embodiment of the present disclosure
  • Figure 4 shows a schematic structural diagram of a detection and sorting system according to an embodiment of the present disclosure
  • Figure 5 shows a schematic structural diagram of a hair liquid dispensing system according to an embodiment of the present disclosure
  • Figure 6 shows a schematic diagram of the principle of preparing double emulsion core-shell structure microspheres according to an embodiment of the present disclosure
  • Figure 7 shows a schematic diagram of the principle of preparing single emulsion core-shell structure microspheres according to an embodiment of the present disclosure
  • Figure 8 shows a schematic diagram of preparing double emulsion core-shell structure microspheres according to an embodiment of the present disclosure
  • Figure 9 shows a schematic diagram of in vitro organ microspheres of different sizes according to embodiments of the present disclosure.
  • Figure 10 shows a schematic diagram of the movement path of the mobile unit according to the embodiment of the present disclosure
  • Figure 11 shows the fluorescence image of VOS dead and alive cells stained after sorting in Example 1 of the present disclosure
  • Figure 12 shows a schematic diagram of matrigel microspheres distributed into well plates according to Example 1 of the present disclosure
  • Figure 13 shows the VOS state diagram cultivated in Example 1 of the present disclosure
  • Figure 14 shows a comparison of Example 1 of the present disclosure and the traditional manual method of preparing cultured VOS
  • Figure 15 shows the growth curve of VOS prepared and cultured in Example 1 of the present disclosure and traditional manual methods
  • Figure 16 shows the fluorescence image of the core-shell structure VOS cultured in Example 1 of the present disclosure.
  • first and second are used for descriptive purposes only and cannot be understood as indicating or implying relative importance or implicitly indicating the quantity of indicated technical features. Therefore, features defined as “first” and “second” may explicitly or implicitly include at least one of these features.
  • “plurality” means at least two, such as two, three, etc., unless otherwise expressly and specifically limited.
  • a first feature being “on” or “below” a second feature may mean that the first and second features are in direct contact, or the first and second features may be in indirect contact through an intermediary. touch.
  • the terms “above”, “above” and “above” the first feature is above the second feature may mean that the first feature is directly above or diagonally above the second feature, or simply means that the first feature is higher in level than the second feature.
  • the first characteristic is “Below”, “below” and “below” the second feature may mean that the first feature is directly below or diagonally below the second feature, or simply means that the first feature has a smaller horizontal height than the second feature.
  • the present disclosure uses microfluidic microdroplet generation and gel solidification technology to achieve uniform and controllable sizes. Preparation of in vitro organoid microspheres.
  • the present disclosure combines an optical detection unit and dielectrophoretic sorting technology on a microfluidic chip to achieve an effective sorting function of VOS and realize automated detection and sorting of VOS. selection, providing an effective quality control method for the preparation of VOS.
  • the present disclosure utilizes a mobile unit whose movement path is controllable to realize automatic distribution of organ microspheres outside the body.
  • the present disclosure implements automatic liquid addition based on a culture liquid pipetting unit.
  • the present disclosure integrates a diaphragm pump and pressure controller, a refrigeration module, a heating unit, a mobile unit, a microsphere fluid distribution unit, a culture fluid pipetting unit and a detection analyzer.
  • the selection system has the advantages of small size, convenient operation, full automation, and easy promotion.
  • the present disclosure is based on a diaphragm pump driving method, which enables one-button operation after one sample addition.
  • the present disclosure proposes a fully automated overall system for the preparation, sorting and distribution of organ microspheres in vitro.
  • the fully automated in vitro organ microsphere preparation, sorting and The total system for distributing culture includes: preparation system 1000, detection and sorting system 2000, and distribution system 3000.
  • the preparation system 1000 is used to prepare organ microspheres in vitro.
  • the preparation system 1000 includes a microsphere preparation flow channel 1100 disposed on a microfluidic chip 100.
  • the microsphere preparation flow channel 1100 Microsphere fluid flow channels 1150 are included.
  • the corresponding microsphere preparation flow channels 1100 are different, specifically:
  • the microsphere preparation flow channel 1100 includes: a cell fluid flow channel 1120 with a shell structure, a cell fluid flow channel 1130 with a core structure, and an oil phase flow.
  • Channel 1110, the cell fluid channel 1120 of the shell structure contains the cell fluid of the shell structure
  • the cell fluid channel 1130 of the core structure contains the cell fluid of the core structure
  • the oil phase channel 1110 contains the oil phase.
  • the cell fluid flow channel 1120 of the shell structure and the cell fluid flow channel 1130 of the core structure merge to form a merged flow channel 1140, and between the cell fluid flow channel 1120 of the shell structure and the cell fluid flow channel 1130 of the core structure, At the confluence of the channels 1130, the cell fluid flow channel 1120 of the shell structure is disposed on both sides of the cell fluid flow channel 1130 of the core structure.
  • the cellular fluid of the shell structure and the cellular fluid of the core structure do not dissolve, but form a three-layer laminar flow including the cellular fluid of the shell structure, the cellular fluid of the core structure, and the cellular fluid of the shell structure in sequence.
  • the cell fluid of the shell structure is distributed on both sides of the cell fluid of the core structure, so that the cell fluid of the shell structure is wrapped on both sides of the cell fluid of the core structure, so that microspheres of the core-shell structure can be formed later.
  • the converging flow channel 1140 and the oil phase flow channel 1110 merge to form a microsphere fluid flow channel 1150.
  • the oil phase flow channel 1110 are provided on both sides of the converging flow channel 1140.
  • the above-mentioned three-layer laminar flow including the cellular fluid of the shell structure, the cellular fluid of the core structure and the cellular fluid of the shell structure are sheared by the oil phase flowing in from both sides, thereby forming microspheres with a core-shell structure, and
  • the core-shell structure in vitro organ microspheres are wrapped in the oil phase.
  • the structure of the core-shell structure in vitro organ microsphere is shown in Figure 8, wherein Figure 8a is a schematic diagram of the core structure, Figure 8b is a schematic diagram of the shell structure, and Figure 8c is a schematic diagram of the core-shell structure.
  • This core-shell structure can realize vascularized co-culture of VOS, further improve the performance of VOS to simulate the organs in the body, lay a foundation for the application of VOS as an in vitro model in the fields of clinical medicine, precision medicine and drug screening, and solve the current problems.
  • the VOS prepared by this method has a simple structure and cannot form vascular structures or co-culture with immune cells.
  • the width of the cell fluid flow channel 1120 of the shell structure and the flow rate of the cell fluid of the shell structure within the cell fluid flow channel 1120 of the shell structure are not particularly limited, and those in the art can proceed according to actual needs. Design, as a preferred solution, the width of the shell-structured cell fluid flow channel 1120 is 100-150 ⁇ m, and the flow rate of the shell-structured cell fluid in the shell-structured cell fluid flow channel 1120 is 0.5-5 ⁇ L/min. .
  • the width of the cellular fluid flow channel 1130 of the nuclear structure and the flow rate of the cellular fluid of the nuclear structure within the cellular fluid channel 1130 of the nuclear structure are not particularly limited, and those in the art can proceed according to actual needs. Design, as a preferred solution, the width of the nuclear structure cell fluid channel 1130 is 100-150 ⁇ m, and the flow rate of the nuclear structure cell fluid in the nuclear structure cell fluid channel 1130 is 0.5-5 ⁇ L/min. .
  • the width of the oil phase flow channel 1110 and the flow rate of the oil phase in the oil phase are not particularly limited. Persons in the art can design according to actual needs. As a preferred solution, the oil phase The width of the flow channel 1110 is 75-300 ⁇ m, and the flow rate of the oil phase in the oil phase flow channel 1110 is 1-20 ⁇ L/min.
  • the cell fluid of the shell structure within the cell fluid channel 1120 of the shell structure includes cells of the shell structure and
  • the first hydrogel serves as a dispersion medium for the cells of the shell structure.
  • the cell fluid of the nuclear structure in the cell fluid channel 1130 of the nuclear structure includes the cells of the nuclear structure and a second hydrogel, and the second hydrogel serves as a dispersion medium for the cells of the nuclear structure.
  • the cells of the shell structure are different from the cells of the core structure, and the first hydrogel and the second hydrogel are different, so that an incompatible multi-layer laminar flow can be formed.
  • the specific types of cells with the shell structure, the specific types of cells with the core structure, the specific types of the first hydrogel, and the specific types of the second hydrogel are not particularly limited.
  • the cells of the shell structure are selected from at least one of umbilical cord vein endothelial cells and immune cells, the cells of the nuclear structure are selected from at least one of tumor cells and stem cells, and the first hydrogel is selected from fibrin.
  • the second hydrogel is at least one selected from the group consisting of Matrigel, fibrinogen and collagen.
  • the preparation system 1000 further includes: a first liquid storage device 1500, the liquid outlet of the first liquid storage device 1500 is connected with the cell fluid flow of the shell structure.
  • the inlet of the channel 1120 is connected, and the first liquid storage device 1500 is used to store the cell fluid of the shell structure; the second liquid storage device 1600, the liquid outlet of the second liquid storage device 1600 is connected with the cell fluid of the core structure.
  • the inlet of the flow channel 1130 is connected, the second liquid storage device 1600 is used to store the cellular fluid of the nuclear structure; the third liquid storage device 1700, the liquid outlet of the third liquid storage device 1700 is connected with the oil phase flow channel 1110 is connected to the inlet, and the third liquid storage device 1700 is used to store the oil phase.
  • the preparation system 1000 also includes: a pressure controller 1300 and a diaphragm pump 1400.
  • the pressure controller 1300 is connected to the first liquid storage device 1500 and the second liquid storage device 1600 respectively. It is connected to the third liquid storage device 1700, and the diaphragm pump 1400 is connected to the pressure controller 1300.
  • the diaphragm pump 1400 is connected to the pressure controller 1300, and the pressure controller 1300 is connected to the liquid storage device.
  • the liquid storage device is connected to the pressure controller 1300 through a tube and connected to the microfluidic chip 100 through a capillary tube extending under the liquid surface.
  • the function of the diaphragm pump 1400 is to generate pressure
  • the function of the pressure controller 1300 is to adjust the pressure generated by the diaphragm pump 1400.
  • the fluid in the liquid storage device is pressed out by the air pressure adjusted by the pressure controller 1300 and then enters the microfluidic chip 100 for VOS. preparation.
  • the air pressure of the pressure controller 1300 the flow rate of the fluid in each channel is adjusted, thereby adjusting the size and spacing distance of VOS and other parameters; at the same time, it also solves the problem of flux in the current preparation process of organ microspheres in vitro
  • the problem is that it is low, the size is uneven and uncontrollable, and it is difficult to achieve standardized preparation by relying on manual operations.
  • the concentration of cells or tissue micro-blocks is constant, the number of cells or tissue micro-blocks can be further determined by adjusting the volume of the microspheres, as shown in Figure 9.
  • the preparation system 1000 also includes: a flow rate control unit 1200, which is connected to the pressure controller 1300.
  • the flow rate control unit 1200 controls the storage by controlling the pressure controller 1300.
  • the air pressure in the liquid device is used to control the flow rate of the fluid in the flow channel.
  • the flow rate control unit 1200 may be an electronic device, such as a mobile phone or a computer.
  • the preparation system 1000 also includes: a refrigeration module (not shown in the figure), the refrigeration module is used to combine the microfluidic chip 100, the first liquid storage device 1500, the second liquid storage device 1500 and the second liquid storage device 1500.
  • the temperatures of the liquid storage device 1600 and the third liquid storage device 1700 are maintained at a certain set temperature (for example, 4°C).
  • the microfluidic chip 100 can be disposed on a refrigeration module (such as a refrigeration plate), in the first liquid storage device 1500 , the second liquid storage device 1600 and the third liquid storage device 1700
  • the refrigeration module is wrapped around the outside.
  • the preparation system 1000 also includes: a heat preservation unit (not shown in the figure), the microfluidic chip 100, the first liquid storage device 1500, the second liquid storage device 1600 and the The third liquid storage device 1700 is disposed in the heat preservation unit, so that the microfluidic chip 100 , the first liquid storage device 1500 , the second liquid storage device 1600 and the third liquid storage device 1700 All are maintained at a low temperature (for example, maintained at 4°C) to avoid Matrigel solidification.
  • a heat preservation unit not shown in the figure
  • the microfluidic chip 100 the first liquid storage device 1500, the second liquid storage device 1600 and the third liquid storage device 1700 All are maintained at a low temperature (for example, maintained at 4°C) to avoid Matrigel solidification.
  • the microsphere preparation flow channel includes: cell fluid flow channel 1160 and oil phase flow channel 1110.
  • the cell fluid flow channel 1160 and the oil phase flow channel 1110 are in phase. They merge to form a microsphere fluid flow channel.
  • the oil phase uses shear force to cut off the cell fluid, forming water-in-oil VOS.
  • the oil phase can cut off the cell fluid from one side, as shown in Figure 7a; the oil phase can also be distributed on both sides of the cell fluid, so that the cell fluid is sheared by the oil phase flowing in from both sides, such as As shown in Figure 7b, water-in-oil VOS is formed.
  • the above-mentioned preparation system 1000 for preparing single emulsion microspheres also includes a device for storing cell fluid and a device for storing oil phase, a pressure controller 1300, a diaphragm pump 1400, a refrigeration module, a heat preservation unit, etc., and their connection methods are as follows: The function is the same as the structure of the preparation system 1000 for preparing double emulsified microspheres, and will not be described again here.
  • a detection and sorting system includes a defective microsphere fluid channel 2100 formed by the bifurcation of the microsphere fluid channel 1150 and qualified microspheres.
  • fluid channel 2200, the defective microsphere fluid channel 2100 and The qualified microsphere fluid flow channels 2200 are all arranged on the microfluidic chip 100, that is, the preparation flow channels and detection and sorting flow channels of microspheres are both arranged on the microfluidic chip 100, integrating preparation and detection. In one.
  • the microsphere fluid channel is provided with an asymmetric electrode 2300 on the corresponding microfluidic chip 100 before bifurcation, and the electric field generated by the corresponding electrode on one side of the defective microsphere fluid channel 2100 is greater than that of the qualified microsphere fluid.
  • the detection and sorting system also includes a signal generator 2500, a detection and sorting control unit 2600 and an optical detection unit 2400.
  • the optical detection unit 2400 is arranged on the corresponding microfluidic chip before the microsphere fluid channel bifurcates. Above 100, the signal generator 2500 is respectively connected to the asymmetric electrode 2300 and the detection and sorting control unit 2600.
  • the detection and sorting control unit 2600 is respectively connected to the optical detection unit 2400 and the signal generator. 2500 is connected.
  • the process of detecting and sorting using the above detection and sorting system is as follows: before the pre-sorting microsphere fluid is bifurcated, an optical detection unit 2400 (such as a microscope lens) is used to observe the pre-sorting microspheres, such as simultaneously observing fluorescence. and side light scattering imaging for observation, and the optical detection unit 2400 sends the observation results to the detection and sorting control unit 2600. If the microspheres are defective before sorting, for example, when a fluorescence signal is captured and/or a void is detected, When soaking, the detection and sorting control unit 2600 issues an instruction to the signal generator 2500, and the signal generator 2500 turns on the asymmetric electrode 2300 to generate an uneven electric field.
  • an optical detection unit 2400 such as a microscope lens
  • the detection and sorting control unit 2600 issues an instruction to the signal generator 2500, and the signal generator 2500 turns on the asymmetric electrode 2300 to generate an uneven electric field.
  • the uneven electric field causes the generation of defective microspheres. deviation into the defective microsphere fluid channel 2100; if there are no defects in the microspheres before sorting, the asymmetric electrode 2300 is not connected so that qualified microspheres enter the qualified microsphere fluid channel 2200. Therefore, the detection and sorting system is an automated operation and uses a combination of fluorescence and bright field detection methods. It can not only screen out dead cells or tissue blocks, but also screen out vacuoles, which improves detection efficiency and Accuracy.
  • the above-mentioned detection and sorting control unit 2600 is an electronic device, such as a mobile phone or a computer.
  • the above-mentioned detection and sorting control unit 2600 and the above-mentioned flow rate control unit may be on the same electronic device.
  • the total system also includes a heating unit (not shown in the figure) for forming qualified microspheres into a solid state (the oil phase of the dispersion medium is still liquid at this time).
  • a heating unit (not shown in the figure) for forming qualified microspheres into a solid state (the oil phase of the dispersion medium is still liquid at this time).
  • One end of the heating unit is connected to the qualified microspheres.
  • the outlets of the fluid flow channels 2200 are connected.
  • the qualified VOS fluid flows out from the outlet of the qualified microsphere fluid channel 2200 and enters the heating unit. Under the heating effect of the heating unit (for example, heated to 25°C), the qualified microspheres form a solid state, and then flow into the distribution distribution together with the oil phase. liquid system.
  • the hair liquid dispensing system is used to distribute the qualified microsphere fluid sorted by the detection and sorting system into the orifice plate and to distribute the qualified microsphere fluid packed in the orifice plate. Add culture medium to the ball.
  • the hair liquid dispensing system 3000 includes: a support plate 3100, a slide 3200 is provided on the support plate 3100; a mobile unit, the mobile unit includes a mobile platform 3500, an X-direction slide rail 3400 and a Y-direction slide rail 3400.
  • Slide rail 3300 The Y-direction slide rail 3300 is vertically disposed on the slideway 3200. The Y-direction slide rail 3300 can move along the Y-direction on the slideway 3200.
  • the X-direction slide rail 3400 is vertically disposed. On the Y-direction slide rail 3300, the X-direction slide rail 3400 can move in the X-direction on the Y-direction slide rail 3300, and the mobile platform 3500 is fixed above the X-direction slide rail 3400; holes plate (not shown in Figure 5), the well plate is arranged on the mobile platform 3500, and a plurality of culture wells are provided on the well plate; a microsphere fluid distribution unit, the microsphere fluid distribution unit includes Microsphere fluid distribution tube 3800, first connecting rod 3700 and first vertical rod 3600. The first vertical rod 3600 is provided on the support plate 3100. The microsphere fluid distribution tube 3800 is supported by the first connecting rod 3700.
  • the microsphere fluid distribution tube 3800 includes a distribution head 3810.
  • the distribution head 3810 is disposed at the lower end of the microsphere fluid distribution tube 3800.
  • the upper end of the microsphere fluid distribution tube 3800 is connected to the upper end of the microsphere fluid distribution tube 3800.
  • the other end of the heating unit is connected to a culture liquid pipetting unit, which includes the culture liquid pipette 3920, a second connecting rod 3910, and a second vertical rod 3900.
  • the second vertical rod 3900 is arranged on the support plate 3100.
  • the culture fluid pipette 3920 is supported above the culture hole through the second connecting rod 3910.
  • the culture fluid pipette 3920 is provided with multiple pipetting tips at the bottom. 3921.
  • the hair liquid distribution system further includes: a hair liquid distribution control unit, which is respectively connected to the moving unit, the microsphere fluid distribution unit and the culture liquid pipetting unit, so The distribution liquid control unit respectively controls the moving path of the mobile unit, the number of VOS distributed in each culture well, and the amount of culture liquid added in each culture well.
  • the heated and solidified VOS fluid is connected to the microsphere fluid distribution tube 3800 through a PTFE tube, and the heated and solidified VOS fluid is distributed through the distribution head to each culture well of the well plate according to actual needs.
  • This distribution method can avoid Due to the vibration caused by the movement of the distribution head, the VOS in the microsphere fluid distribution tube 3800 may be bonded in multiple ways, ensuring the stability of VOS distribution.
  • the microsphere fluid distribution tube 3800 is vertically downward and has a fixed position, thereby reducing the unstable influence of VOS distribution due to movement.
  • the orifice plate is placed above the mobile platform 3500, and by moving the mobile platform 3500 according to a preset route, the cured VOS flows out into each hole of the orifice plate through the distribution head.
  • the number of VOS in each hole can be adjusted according to actual needs.
  • the mobile unit can move according to a certain path according to actual needs, wherein the Y-direction slide rail 3300 can move along the Y-direction on the slide, thereby controlling the movement of the mobile platform 3500 in the Y-direction, and the X-direction slide rail 3300 can move along the Y-direction.
  • the rail 3400 can move along the X direction on the Y-direction slide rail 3300, thereby controlling the movement of the mobile platform 3500 in the X direction. This ensures that VOS is allocated to each required hole, and there is no need to change the plate midway. operate.
  • the moving path of the well plate can be set by the distribution liquid control unit, and can be personalized according to the well plate and test requirements to ensure that the distributed VOS can meet the needs of later experiments.
  • Figure 10 is a schematic diagram of one of the paths.
  • the culture liquid pipetting unit can be controlled to move to the top of the well plate to add culture liquid.
  • the bottom of the culture medium pipette 3920 can be connected with pipette tips of different specifications and quantities. Move the culture medium pipette 3920 to the top of the liquid storage tank.
  • the pipette head will draw a certain amount of liquid from the culture liquid storage tank through negative pressure.
  • After adding culture medium move to the top of the well plate and release the negative pressure to allow the culture medium to flow out into the well plate.
  • the amount of liquid added and the number and specifications of the pipette tips connected to the bottom of the culture medium pipette 3920 can be matched according to the specifications of the well plate used. Automatic addition of liquid is performed immediately after VOS distribution to avoid damage to cell activity caused by Matrigel dehydration. Thus, the hair liquid dispensing system operates automatically.
  • the first connecting rod 3700 is configured to rotate circumferentially with the first vertical rod 3600 as an axis. After the microsphere fluid distribution tube 3800 completes distributing the heated and formed microsphere fluid, the first vertical rod can be rotated.
  • 3600 is a shaft that rotates the first connecting rod 3700 circumferentially to move the microsphere fluid distribution tube 3800 away from the top of the orifice plate to avoid affecting the subsequent operation of the culture fluid pipetting unit.
  • the first vertical rod 3600 is configured to be telescopic up and down, thereby enabling the movement of the first vertical rod 3600 on the Z-axis, thereby realizing the movement of the microsphere fluid distribution tube 3800 on the Z-axis.
  • the second vertical rod 3900 is configured to be telescopic up and down, which can realize the movement of the second vertical rod 3900 on the Z-axis, thereby realizing the movement of the culture medium pipette 3920 on the Z-axis; in addition, when the microsphere When the fluid distribution unit distributes the heated and formed microsphere fluid, the second vertical rod 3900 is raised, thereby driving the culture solution pipette 3920 and the second connecting rod to rise to avoid affecting the distribution operation of the microsphere fluid distribution unit; when After the distribution of the microsphere fluid distribution unit is completed, the second vertical rod 3900 is lowered, thereby driving the culture solution pipette 3920 and the second connecting rod to lower, so that the culture solution pipette 3920 is just above the culture well, and the dispensing Add culture fluid to the qualified microspheres in the well plate.
  • the overall system solves the problems of low throughput, non-uniform and uncontrollable size, poor reproducibility and relatively large size in traditional preparation methods. It is difficult to achieve automated preparation and distribution, which in turn limits its application in basic research and clinical diagnosis.
  • This disclosure uses a microfluidic droplet generation and gel solidification system to prepare VOS with uniform and controllable sizes, and realizes its automated preparation; at the same time, a detection and sorting function is integrated on the chip to detect VOS with a lot of dead cells or no cells.
  • the modular system constructed in this disclosure can realize the automated preparation and culture of VOS, is simple to operate and pollution-free, provides a reproducible in vitro biological model for drug screening and efficacy evaluation, and has good application prospects and promotion value.
  • the above-mentioned system can greatly save raw materials and dosage of drugs, greatly reduce costs and labor, and improve the efficiency of drug screening and new drug research and development, which has great economic benefits.
  • Another aspect of the present disclosure provides a method for in vitro organ microsphere preparation, sorting, and distribution culture using the overall system described in the above embodiments. According to an embodiment of the present disclosure, the method includes:
  • S100 Prepare in vitro organ microspheres in the microsphere preparation flow channel.
  • the in vitro organ microspheres are wrapped in the oil phase to form pre-sorting microsphere fluid, which specifically includes the following steps:
  • S120 Combine the cellular fluid of the shell structure and the cellular fluid of the core structure to form a merged fluid, and distribute the cellular fluid of the shell structure outside the cellular fluid of the core structure;
  • S130 Combine the combined fluid and the oil phase to form core-shell structure extracorporeal organ microspheres, and wrap the core-shell structure extracorporeal organ microspheres in the oil phase.
  • an optical detection unit is used to observe the pre-sorting microspheres.
  • the optical detection unit sends the observation results to the detection and sorting control unit. If the pre-sorting microsphere fluid is bifurcated, If there are defects in the microspheres, the detection and sorting control unit will issue instructions to the signal generator, and the signal generator will turn on the asymmetric electrode to generate an uneven electric field, and the uneven electric field will cause the defects to The microspheres deviate and enter the defective microsphere fluid channel 2100; if there are no defects in the microspheres before sorting, the asymmetric electrode is not connected so that qualified microspheres enter the qualified microsphere fluid channel 2200.
  • a microscope lens can be used to observe fluorescence and side light scattering imaging at the same time, and the computer control system analyzes the observation results.
  • an instruction is issued to the signal generator.
  • the signal generator connects the electrodes integrated on the chip to generate a non-uniform electric field, causing the VOS that generates the signal to deviate into the defective microsphere fluid channel 2100 for separation.
  • side scatter detection is performed to detect the particle size of VOS.
  • the signal generator is triggered to separate the VOS.
  • the principle is the same as above. Dual-channel detection can simultaneously separate low-activity VOS and vacuoles, ensuring that all VOS obtained are highly active.
  • the detection method provided by the disclosed method is to detect non-target VOS, that is, to detect low activity and vacuoles.
  • this method chooses to stain non-target VOS, which avoids the damage caused by labeling to the target, has a protective effect on high-activity VOS, and has a higher separation efficiency.
  • the optical detection unit can simultaneously detect fluorescence and side scattering of VOS, and apply an asymmetric electric field through electrodes integrated on the chip to shift the VOS to achieve separation.
  • the VOS that has passed the test will continue to flow out from the outlet through the flow channel in the chip, and then pass through the 25°C heating plate for solidification treatment before entering the liquid distribution system.
  • S300 Use a liquid dispensing system to distribute the qualified microsphere fluid in the well plate, and add culture fluid to the qualified microspheres distributed in the well plate.
  • the heated and solidified VOS fluid is connected to the microsphere fluid distribution tube through a PTFE tube, and the heated and solidified VOS fluid is distributed through the distribution head to each culture well of the well plate according to actual needs.
  • the orifice plate is placed above the moving platform, and the solidified VOS flows out through the distribution head into each hole of the orifice plate by making the moving platform move along a preset route.
  • the culture liquid pipetting unit can be controlled to move to the top of the well plate to add culture liquid.
  • the bottom of the culture medium pipette can be connected to pipette tips of different specifications and quantities. Move the culture medium pipette to the top of the liquid storage tank.
  • the pipette head will draw a certain amount of culture medium from the culture liquid storage tank through negative pressure. Then, move to the top of the well plate and release the negative pressure to allow the culture medium to flow out into the well plate.
  • the amount of liquid added and the number and specifications of the pipette tips connected to the bottom of the culture medium pipette can be matched according to the specifications of the well plate used. Automatic addition of liquid is performed immediately after VOS distribution to avoid damage to cell activity caused by Matrigel dehydration.
  • the fully automated in vitro organ microsphere preparation, sorting and distribution culture method according to the embodiments of the present disclosure has all the advantages of the fully automated in vitro organ microsphere preparation, sorting and distribution culture system described in the above embodiments. This will not be described again.
  • the preparation system shown in Figure 3 and Figure 7 is used to prepare microspheres with a single emulsion structure.
  • the method is as follows:
  • the detection and sorting system described in Figures 2 and 4 is used to screen the preparation emulsified microspheres prepared above, and the microspheres with red fluorescence or vacuoles are screened out and flow into the defective microsphere fluid channel, and the active The higher microspheres flow into the qualified microsphere fluid channel, and the sorted VOS is stained for dead and alive cells again.
  • the fluorescence display is shown in Figure 11.
  • the fluorescence picture is all green (that is, the white points or gray points in the picture are green Fluorescence), there is no red color, indicating that the activity of VOS after sorting is higher.
  • the qualified VOS fluid flows out from the outlet of the qualified microsphere fluid channel and enters the heating unit. Under the heating effect of the heating unit (25°C), the qualified microspheres form a solid state, and then flow into the hair liquid distribution system together with the oil phase.
  • the detection and sorting system described in Figure 5 is used to automatically distribute the qualified microsphere fluid to each culture well in the 384-well plate, as shown in Figure 12. Then use a culture medium pipetting unit to add culture medium to each culture well, and finally put it into a cell culture incubator for culture. VOS was photographed and observed every day, as shown in Figure 13. It can be seen from Figure 13 that the size of each microsphere is uniform. At the same time, it was compared with the VOS prepared and cultured by traditional manual methods. The results are shown in Figure 14.
  • Double emulsion core-shell structure microspheres are prepared using the preparation system shown in Figure 2 and Figure 3. The method is as follows:
  • the intestinal tumor cells in the nuclear layer from the patient were transfected with a virus carrying the GFP reporter gene, and then mixed with matrigel evenly and then added to the nuclear layer cell fluid storage device.
  • the human umbilical vein endothelial cells in the shell layer were transfected with a virus carrying the RFP reporter gene. Then mix it evenly with collagen and add it to the shell cell liquid storage device. Add the oil phase fluorine oil HFE7000 to the oil phase storage device and connect the chip.
  • the above-mentioned double emulsion core-shell structure microspheres were distributed into each culture well in a 384-well plate. Then use a culture medium pipetting unit to add culture medium to each culture well, and finally put it into a cell culture incubator for culture.
  • the cells in the middle nuclear layer are intestinal tumor cells from the patient.
  • the fluorescent staining is green, and the outer shell is human umbilical vein.
  • the vascular structure formed by endothelial cells is fluorescently stained red, with red distributed in the outer layer (as shown in B) and green in the middle layer (as shown in A). Therefore, it can be proved that the VOS prepared by this method has a core-shell structure.
  • the VOS has a vascular structure (as shown in C).
  • references to the terms “one embodiment,” “some embodiments,” “an example,” “specific examples,” or “some examples” or the like means that specific features are described in connection with the embodiment or example. , structures, materials, or features are included in at least one embodiment or example of the present disclosure. In this specification, the schematic expressions of the above terms are not necessarily directed to the same embodiment or example. Furthermore, the specific features, structures, materials or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Furthermore, those skilled in the art may combine and combine different embodiments or examples and features of different embodiments or examples described in this specification unless they are inconsistent with each other.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Sustainable Development (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Physics & Mathematics (AREA)
  • Computer Hardware Design (AREA)
  • Molecular Biology (AREA)
  • Fluid Mechanics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Electromagnetism (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The present disclosure relates to the technical field of in-vitro organs, and in particular to a total system and a method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microspheres.

Description

全自动化体外器官微球制备、分选以及分配培养的总系统和方法Total system and method for fully automated in vitro organ microsphere preparation, sorting, and distribution culture
优先权信息priority information
本公开请求2022年8月2日向中国国家知识产权局提交的专利申请202210919531.5的优先权和权益,并且通过参照将其全文并入此处。This disclosure claims the priority and rights of patent application 202210919531.5 filed with the State Intellectual Property Office of China on August 2, 2022, and the full text of which is incorporated herein by reference.
技术领域Technical field
本公开涉及体外器官技术领域,具体地,本公开涉及全自动化体外器官微球制备、分选以及分配培养的总系统和方法。The present disclosure relates to the field of in vitro organ technology. Specifically, the present disclosure relates to a total system and method for fully automated in vitro organ microsphere preparation, sorting, and distribution culture.
背景技术Background technique
据统计,一种新药的研发平均需要耗资10亿美元以上,历时10年以上,而实际上的资金和时间投入要远远高于这个数字。目前,药物筛选最常用的方法主要是基于动物和细胞实验的药效学模型。但由于动物实验周期长,劳动强度大,操作技术要求高,成本高,且因动物与人之间存在的种族差异导致筛选的药物与临床应用之间尚有很大距离,因而发展缓慢,未能进行大规模筛选,也因涉及动物权益保护等问题备受争议。而传统的细胞实验中细胞大多为二维贴壁培养,且为单种细胞培养,与细胞在体内的生长微环境差距较大,且此状态下的细胞无法表现出体内细胞的完整功能,从而导致体外细胞模型对药物的反应不能体现出药物在体内的真实反应。According to statistics, the average research and development of a new drug costs more than 1 billion US dollars and takes more than 10 years. However, the actual investment of money and time is much higher than this figure. Currently, the most commonly used methods for drug screening are mainly pharmacodynamic models based on animal and cell experiments. However, due to the long cycle of animal experiments, high labor intensity, high operational technical requirements and high costs, and due to the racial differences between animals and humans, there is still a long distance between the screened drugs and clinical applications, so development is slow and has not yet been completed. It can carry out large-scale screening, but it has also been controversial because of issues such as animal rights protection. In traditional cell experiments, most of the cells are two-dimensional adherent culture and single cell culture, which is quite different from the growth microenvironment of the cells in the body, and the cells in this state cannot show the complete functions of the cells in the body, so As a result, the response of the in vitro cell model to the drug cannot reflect the true response of the drug in the body.
近些年类器官的出现为药物筛选提供了一种良好的体外模型。类器官是利用胚胎干细胞,多能干细胞或成体体细胞在一定的培养环境和细胞外基质的支撑作用下形成的具有三维结构的,在功能上接近器官的多细胞结构。相比于细胞系培养,类器官具有三维微结构,更接近体内组织的状态,在肿瘤模型中能保留肿瘤的异质性,具有在药物筛选、病理研究及精准医疗等多个领域广泛应用的潜力。目前传统的类器官培养方法主要有使用基质胶作为支撑基质,将类器官种子与基质胶混合后通过移液枪接种到培养皿中,在37℃环境下使基质胶固化从而达到三维培养的效果。然而,这种方法培养的类器官大小尺寸以及培养皿中形成的类器官微球数量均不可控,且全程为人工操作,效率较低,类器官培养状态受操作人员差异性影响较大,不利于类器官的标准化和通量化培养,同时也无法满足药物筛选的需求。超低粘附U型孔板也被用来进行类器官培养,这种方法对孔板表面材料进行改性,使细胞在其表面不会贴壁生长,再利用原型孔底使细胞因为重力原因聚集在孔板底部成球生长从而达到三维培养的目的,但是这种方法不便于使用基质胶,因而也无法提供类器官生长所需要的营养物质。此外,还有利用3D打印技术进行细胞三维构建后模拟体内器官的三维结构,但是这种方法存在对体内器官结构,细胞种类等了解及认识不够,无法完全在体外进行模拟,而重建的模型也无法重现体内器官的功能。The emergence of organoids in recent years provides a good in vitro model for drug screening. Organoids are multicellular structures with a three-dimensional structure that are functionally close to organs, formed from embryonic stem cells, pluripotent stem cells or adult somatic cells under a certain culture environment and the support of extracellular matrix. Compared with cell line culture, organoids have a three-dimensional microstructure that is closer to the state of in vivo tissues. They can retain tumor heterogeneity in tumor models and have wide application in many fields such as drug screening, pathological research, and precision medicine. potential. At present, the traditional organoid culture method mainly uses Matrigel as the supporting matrix. The organoid seeds are mixed with Matrigel and then inoculated into the culture dish through a pipette. The Matrigel is solidified at 37°C to achieve the effect of three-dimensional culture. . However, the size of the organoids cultured by this method and the number of organoid microspheres formed in the culture dish are uncontrollable, and the entire process is manual operation, which has low efficiency. The culture state of the organoids is greatly affected by the differences between operators and cannot be controlled. It is conducive to the standardization and throughput culture of organoids, but it also cannot meet the needs of drug screening. Ultra-low adhesion U-shaped well plates are also used for organoid culture. This method modifies the surface material of the well plate so that cells will not grow adherently on its surface, and then uses the bottom of the prototype well to allow cells to grow due to gravity. They gather at the bottom of the well plate and grow into balls to achieve the purpose of three-dimensional culture. However, this method is inconvenient to use Matrigel and therefore cannot provide the nutrients needed for organoid growth. In addition, there is also the use of 3D printing technology to construct three-dimensional cells and then simulate the three-dimensional structure of organs in the body. However, this method does not have enough understanding and knowledge of the structure of organs and cell types in the body, so it cannot be completely simulated in vitro, and the reconstructed model is also The function of organs in the body cannot be reproduced.
专利CN110004111B公开了一种类器官球体的制备方法,此方法利用注射泵及三通装置实现类器官液滴微球制备。油相为氟油,水相为matrigel和细胞混合物,将水相和油相分别注入注射器中,注射器连接三通装置并用注射泵驱动注射器,注射泵放入冰箱(4℃)中以维持matrigel不会发生凝固,进而通过注射泵驱动注射器在三通装置中制备类器官微球。专利CN110042077B公开了一种类器官球体的高通量培养方法,本方法为上一专利的延续,利用上面提到的专利进行得到类器官微球后进行加热,并与3D打印平台联动将类器官球体进行分配。Patent CN110004111B discloses a method for preparing organoid spheroids. This method uses a syringe pump and a three-way device to prepare organoid droplet microspheres. The oil phase is fluorine oil, and the water phase is a mixture of matrigel and cells. Inject the water phase and oil phase into a syringe respectively. The syringe is connected to the tee device and a syringe pump is used to drive the syringe. The syringe pump is placed in the refrigerator (4°C) to maintain the matrigel. Coagulation occurs and organoid microspheres are prepared in a three-way device via a syringe driven by a syringe pump. Patent CN110042077B discloses a high-throughput culture method for organoid spheroids. This method is a continuation of the previous patent. The above-mentioned patent is used to obtain organoid microspheres, then heated, and linked with the 3D printing platform to convert the organoid spheroids. Make allocations.
以上两项专利技术的缺点为:1.整个系统为多个仪器(如冰箱)装置简单搭建而成,体积大,操作麻烦,不利于推广;2.系统无法放入生物安全柜中进行操作,无法保证无菌的环境,制备的类器官可能存在污染的风险;3.系统缺少实时观测模块,无法实现观测及质量监控功能;4.系统缺少自动加液功能很难实现真正意义上的高通量培养,类器官的存活率没有保证;5.由于涉及注射泵及注射器,油相及水相样品更换及添加操作繁琐且存在气泡等干扰因素;6.类器官分发采用3D打印平台,在其运动过程中,容易造成管道(tubing)中类器官的扰动,进而影响分发的准确度。The disadvantages of the above two patented technologies are: 1. The entire system is simply built with multiple instruments (such as refrigerators), which is large in size, troublesome to operate, and is not conducive to promotion; 2. The system cannot be placed in a biological safety cabinet for operation. A sterile environment cannot be guaranteed, and the prepared organoids may have the risk of contamination; 3. The system lacks a real-time observation module and cannot realize observation and quality monitoring functions; 4. The system lacks an automatic liquid addition function and it is difficult to achieve high-pass performance in the true sense. The survival rate of organoids is not guaranteed due to high-volume culture; 5. Since syringe pumps and syringes are involved, the replacement and addition of oil and water phase samples are cumbersome and there are interfering factors such as bubbles; 6. The organoids are distributed using a 3D printing platform. During the movement, it is easy to cause disturbance of the organoids in the tubing, thereby affecting the accuracy of distribution.
发明内容Contents of the invention
本公开旨在至少在一定程度上解决相关技术中的技术问题之一。为此,本公开的一个目的在于提供一种全自动化体外器官微球制备、分选以及分配培养的总系统和方法。本公开构建的模块化系统能够实 现VOS的自动化制备、检测分选和分配发液培养,操作简单且无污染,为药物筛选及药效评价提供重现性良好的体外生物模型,具有良好的应用前景及推广价值。The present disclosure aims to solve one of the technical problems in the related art, at least to a certain extent. To this end, one object of the present disclosure is to provide a fully automated overall system and method for in vitro organ microsphere preparation, sorting, and distribution culture. The modular system constructed by this disclosure can realize Nowadays, the automated preparation, detection, sorting, and distribution of hair fluid for culture of VOS are simple to operate and pollution-free. It provides a reproducible in vitro biological model for drug screening and efficacy evaluation, and has good application prospects and promotion value.
为此,本公开一方面提供一种全自动化体外器官微球制备、分选以及分配培养的总系统。根据本公开的实施例,所述全自动化体外器官微球制备、分选以及分配培养的总系统包括:To this end, on the one hand, the present disclosure provides a fully automated total system for in vitro organ microsphere preparation, sorting, and distribution culture. According to an embodiment of the present disclosure, the total system for fully automated in vitro organ microsphere preparation, sorting and distribution culture includes:
制备系统,所述制备系统用于制备体外器官微球,所述制备系统包括设置在微流控芯片上的微球制备流道,所述微球制备流道包括微球流体流道;Preparation system, the preparation system is used to prepare in vitro organ microspheres, the preparation system includes a microsphere preparation flow channel provided on a microfluidic chip, the microsphere preparation flow channel includes a microsphere fluid flow channel;
检测分选系统,所述检测分选系统包括由所述微球流体流道分岔形成的缺陷微球流体流道和合格微球流体流道,所述缺陷微球流体流道和所述合格微球流体流道均设置在所述微流控芯片上,所述微球流体流道在分岔前对应的微流控芯片上设置不对称电极,且所述缺陷微球流体流道一侧对应的电极产生的电场大于所述合格微球流体流道一侧对应的电极产生的电场,所述检测分选系统还包括信号发生器、检测分选控制单元和光学检测单元,所述光学检测单元设置在所述微球流体流道在分岔前对应的微流控芯片的上方,所述信号发生器分别与所述不对称电极和所述检测分选控制单元相连,所述检测分选控制单元分别与所述光学检测单元和所述信号发生器相连;Detection and sorting system, the detection and sorting system includes a defective microsphere fluid channel and a qualified microsphere fluid channel formed by the bifurcation of the microsphere fluid channel, the defective microsphere fluid channel and the qualified microsphere fluid channel The microsphere fluid channels are all arranged on the microfluidic chip. The microsphere fluid channels are provided with asymmetric electrodes on the corresponding microfluidic chip before bifurcation, and one side of the defective microsphere fluid channel The electric field generated by the corresponding electrode is greater than the electric field generated by the corresponding electrode on one side of the qualified microsphere fluid channel. The detection and sorting system also includes a signal generator, a detection and sorting control unit and an optical detection unit. The optical detection unit The unit is arranged above the microfluidic chip corresponding to the microsphere fluid channel before bifurcation, and the signal generator is connected to the asymmetric electrode and the detection and sorting control unit respectively, and the detection and sorting control unit The control unit is connected to the optical detection unit and the signal generator respectively;
分配发液系统,所述分配发液系统用于将经过所述检测分选系统分选得到的合格微球流体分装在孔板中以及对分装在所述孔板中的合格微球添加培养液。Dispensing hair liquid system, the hair liquid distributing system is used for distributing the qualified microsphere fluid sorted by the detection and sorting system into the orifice plate and adding the qualified microsphere fluid packed in the orifice plate. Culture fluid.
根据本公开上述实施例的全自动化体外器官微球制备、分选以及分配培养的总系统,本公开构建的模块化系统能够实现VOS的自动化制备、检测分选和分配发液培养,操作简单且无污染,为药物筛选及药效评价提供重现性良好的体外生物模型,具有良好的应用前景及推广价值。同时在芯片上集成检测分选功能,对死细胞较多或无细胞的VOS进行了筛选,保证得到的VOS全部为高活性,实现目标VOS的有效分选。According to the overall system of fully automated in vitro organ microsphere preparation, sorting, and distribution culture according to the above embodiments of the present disclosure, the modular system constructed by the present disclosure can realize the automated preparation, detection, sorting, and distribution of hair fluid culture of VOS, and is simple to operate and It is pollution-free, provides a reproducible in vitro biological model for drug screening and efficacy evaluation, and has good application prospects and promotion value. At the same time, the detection and sorting function is integrated on the chip to screen VOS with more dead cells or no cells to ensure that all VOS obtained are highly active and achieve effective sorting of target VOS.
根据本公开实施例的全自动化体外器官微球制备、分选以及分配培养的总系统还可以具有如下附加的技术特征:The total system for fully automated in vitro organ microsphere preparation, sorting, and distribution culture according to embodiments of the present disclosure may also have the following additional technical features:
根据本公开的实施例,所述微球制备流道包括:壳结构的细胞流体流道、核结构的细胞流体流道和油相流道,所述壳结构的细胞流体流道和所述核结构的细胞流体流道相汇合形成汇合流道,所述汇合流道与所述油相流道相汇合形成微球流体流道,在所述壳结构的细胞流体流道和所述核结构的细胞流体流道的汇合处,所述壳结构的细胞流体流道设置在所述核结构的细胞流体流道的两侧,在所述汇合流道与所述油相流道的汇合处,所述油相流道设置在所述汇合流道的两侧。According to an embodiment of the present disclosure, the microsphere preparation flow channel includes: a cell fluid flow channel of a shell structure, a cell fluid flow channel of a core structure, and an oil phase flow channel. The cell fluid flow channel of the shell structure and the core structure are The cell fluid flow channels of the structure merge to form a merged flow channel, and the merged flow channel merges with the oil phase flow channel to form a microsphere fluid flow channel. Between the cell fluid flow channel of the shell structure and the core structure, At the confluence of the cell fluid flow channels, the cell fluid flow channels of the shell structure are arranged on both sides of the cell fluid flow channels of the core structure. At the confluence of the merge flow channel and the oil phase flow channel, the The oil phase flow channel is arranged on both sides of the converging flow channel.
根据本公开的实施例,所述制备系统还包括:第一储液装置,所述第一储液装置的出液口与所述壳结构的细胞流体流道的入口相连,所述第一储液装置用于储存壳结构的细胞流体;According to an embodiment of the present disclosure, the preparation system further includes: a first liquid storage device, the liquid outlet of the first liquid storage device is connected to the inlet of the cell fluid flow channel of the shell structure, the first liquid storage device The fluid device is used to store cellular fluids in the shell structure;
第二储液装置,所述第二储液装置的出液口与所述核结构的细胞流体流道的入口相连,所述第二储液装置用于储存核结构的细胞流体;a second liquid storage device, the liquid outlet of the second liquid storage device is connected to the inlet of the cell fluid flow channel of the nuclear structure, and the second liquid storage device is used to store the cell fluid of the nuclear structure;
第三储液装置,所述第三储液装置的出液口与所述油相流道的入口相连,所述第三储液装置用于储存油相;A third liquid storage device, the liquid outlet of the third liquid storage device is connected to the inlet of the oil phase flow channel, and the third liquid storage device is used to store the oil phase;
压力控制器和隔膜泵,所述压力控制器分别与所述第一储液装置、所述第二储液装置和所述第三储液装置相连,所述隔膜泵与所述压力控制器相连。A pressure controller and a diaphragm pump. The pressure controller is connected to the first liquid storage device, the second liquid storage device and the third liquid storage device respectively. The diaphragm pump is connected to the pressure controller. .
根据本公开的实施例,所述制备系统还包括:流速控制单元,所述流速控制单元与所述压力控制器相连。According to an embodiment of the present disclosure, the preparation system further includes: a flow rate control unit connected to the pressure controller.
根据本公开的实施例,所述制备系统还包括:制冷模块,所述制冷模块用于将所述微流控芯片、所述第一储液装置、所述第二储液装置和所述第三储液装置的温度维持在某一设定温度。According to an embodiment of the present disclosure, the preparation system further includes: a refrigeration module, the refrigeration module is used to combine the microfluidic chip, the first liquid storage device, the second liquid storage device and the third liquid storage device. The temperature of the three liquid storage devices is maintained at a certain set temperature.
根据本公开的实施例,所述制备系统还包括:保温单元,所述微流控芯片、所述第一储液装置、所述第二储液装置和所述第三储液装置均设置在所述保温单元内。According to an embodiment of the present disclosure, the preparation system further includes: a heat preservation unit, the microfluidic chip, the first liquid storage device, the second liquid storage device and the third liquid storage device are all arranged in inside the insulation unit.
根据本公开的实施例,所述壳结构的细胞流体流道的宽度为100~150μm,所述壳结构的细胞流体流道内的壳结构的细胞流体的流速为0.5~5μL/min。According to an embodiment of the present disclosure, the width of the cell fluid flow channel of the shell structure is 100-150 μm, and the flow rate of the cell fluid of the shell structure in the cell fluid flow channel of the shell structure is 0.5-5 μL/min.
根据本公开的实施例,所述核结构的细胞流体流道的宽度为100~150μm,所述核结构的细胞流体流道内的核结构的细胞流体的流速为0.5~5μL/min。 According to an embodiment of the present disclosure, the width of the cellular fluid channel of the nuclear structure is 100-150 μm, and the flow rate of the cellular fluid of the nuclear structure in the cellular fluid channel of the nuclear structure is 0.5-5 μL/min.
根据本公开的实施例,所述油相流道的宽度为75~300μm,所述油相流道内的油相的流速为1~20μL/min。According to an embodiment of the present disclosure, the width of the oil phase flow channel is 75-300 μm, and the flow rate of the oil phase in the oil phase flow channel is 1-20 μL/min.
根据本公开的实施例,所述壳结构的细胞流体流道内的壳结构的细胞流体包括壳结构的细胞和第一水凝胶,所述核结构的细胞流体流道内的核结构的细胞流体包括核结构的细胞和第二水凝胶,所述壳结构的细胞与所述核结构的细胞不同,所述第一水凝胶和所述第二水凝胶不同,所述壳结构的细胞选自脐带静脉内皮细胞和免疫细胞中的至少一种,所述核结构的细胞选自肿瘤细胞和干细胞中的至少一种,所述第一水凝胶选自纤维蛋白原、胶原和海藻酸盐中的至少一种,所述第二水凝胶选自基质胶、纤维蛋白原和胶原中的至少一种。According to an embodiment of the present disclosure, the cellular fluid of the shell structure within the cellular fluid channel of the shell structure includes cells of the shell structure and the first hydrogel, and the cellular fluid of the core structure within the cellular fluid channel of the core structure includes The cells of the core structure and the second hydrogel, the cells of the shell structure are different from the cells of the core structure, the first hydrogel and the second hydrogel are different, and the cells of the shell structure are selected From at least one of umbilical cord vein endothelial cells and immune cells, the cells of the nuclear structure are selected from at least one of tumor cells and stem cells, and the first hydrogel is selected from the group consisting of fibrinogen, collagen and alginate At least one of the second hydrogel is selected from at least one of Matrigel, fibrinogen and collagen.
根据本公开的实施例,所述微球制备流道包括:细胞流体流道和油相流道,所述细胞流体流道和所述油相流道相汇合形成微球流体流道。According to an embodiment of the present disclosure, the microsphere preparation flow channel includes: a cell fluid flow channel and an oil phase flow channel, and the cell fluid flow channel and the oil phase flow channel merge to form a microsphere fluid flow channel.
根据本公开的实施例,所述总系统还包括加热单元,用于将合格微球形成固态,所述加热单元的一端与所述合格微球流体流道的出口相连;According to an embodiment of the present disclosure, the total system further includes a heating unit for forming the qualified microspheres into a solid state, and one end of the heating unit is connected to the outlet of the qualified microsphere fluid flow channel;
所述分配发液系统包括:The hair liquid dispensing system includes:
支撑板,所述支撑板上设有滑道;A support plate with a slideway provided on the support plate;
移动单元,所述移动单元包括移动平台、X方向滑轨和Y方向滑轨,所述Y方向滑轨垂直设置在所述滑道上,所述Y方向滑轨可在所述滑道上沿Y方向移动,所述X方向滑轨垂直设置在所述Y方向滑轨上,所述X方向滑轨可在所述Y方向滑轨上沿X方向移动,所述移动平台固定在所述X方向滑轨的上方;Mobile unit, the mobile unit includes a mobile platform, an X-direction slide rail and a Y-direction slide rail. The Y-direction slide rail is vertically arranged on the slide rail. The Y-direction slide rail can move along the Y-direction on the slide rail. move, the X-direction slide rail is vertically arranged on the Y-direction slide rail, the X-direction slide rail can move along the X-direction on the Y-direction slide rail, and the mobile platform is fixed on the X-direction slide rail. above the rail;
孔板,所述孔板设置在所述移动平台上,所述孔板上设有多个培养孔;A well plate, the well plate is arranged on the mobile platform, and the well plate is provided with a plurality of culture wells;
微球流体分配单元,所述微球流体分配单元包括微球流体分配管、第一连接杆和第一立杆,所述第一立杆设置在所述支撑板上,所述微球流体分配管通过第一连接杆支撑在所述培养孔的上方,所述微球流体分配管包括分配头,所述分配头设置在所述微球流体分配管的下端,所述微球流体分配管的上端与所述加热单元的另一端相连;Microsphere fluid distribution unit, the microsphere fluid distribution unit includes a microsphere fluid distribution tube, a first connecting rod and a first vertical rod, the first vertical rod is arranged on the support plate, the microsphere fluid distribution unit The pipe is supported above the culture hole through a first connecting rod. The microsphere fluid distribution tube includes a distribution head. The distribution head is provided at the lower end of the microsphere fluid distribution tube. The microsphere fluid distribution tube has The upper end is connected to the other end of the heating unit;
培养液移液单元,所述培养液移液单元包括所述培养液移液器、第二连接杆和第二立杆,所述第二立杆设置在所述支撑板上,所述培养液移液器通过第二连接杆支撑在所述培养孔的上方,所述培养液移液器底部设有多个移液枪头。Culture liquid pipetting unit, the culture liquid pipetting unit includes the culture liquid pipette, a second connecting rod and a second vertical rod, the second vertical rod is arranged on the support plate, the culture liquid pipetting unit The pipette is supported above the culture hole through a second connecting rod, and a plurality of pipette tips are provided at the bottom of the culture liquid pipette.
根据本公开的实施例,所述分配发液系统还包括:分配发液控制单元,所述分配发液控制单元分别与所述移动单元、所述微球流体分配单元和所述培养液移液单元相连。According to an embodiment of the present disclosure, the hair liquid dispensing system further includes: a hair liquid distributing control unit, which is respectively connected to the moving unit, the microsphere fluid dispensing unit and the culture liquid pipetting unit. units are connected.
根据本公开的实施例,所述第一连接杆设置为可以所述第一立杆为轴周向转动,所述第一立杆设置为可上下伸缩,所述第二立杆设置为可上下伸缩。According to an embodiment of the present disclosure, the first connecting rod is configured to rotate circumferentially about the axis of the first vertical rod, the first vertical rod is configured to be telescopic up and down, and the second vertical rod is configured to be able to move up and down. Telescopic.
本公开另一方面提供一种采用以上实施例所述的总系统进行体外器官微球制备、分选以及分配培养的方法。根据本公开的实施例,所述方法包括:Another aspect of the present disclosure provides a method for in vitro organ microsphere preparation, sorting, and distribution culture using the overall system described in the above embodiments. According to an embodiment of the present disclosure, the method includes:
(1)在微球制备流道制备得到体外器官微球,所述体外器官微球包裹在油相中形成分选前微球流体;(1) In vitro organ microspheres are prepared in the microsphere preparation flow channel, and the in vitro organ microspheres are wrapped in an oil phase to form a pre-sorting microsphere fluid;
(2)在所述分选前微球流体分岔前,采用光学检测单元对分选前微球进行观测,所述光学检测单元将观测结果发送至检测分选控制单元,如果所述分选前微球存在缺陷,则所述检测分选控制单元向信号发生器发出指令,所述信号发生器则接通不对称电极,以便产生不均匀电场,所述不均匀电场使缺陷微球发生偏离进入缺陷微球流体流道;(2) Before the pre-sorting microsphere fluid bifurcates, an optical detection unit is used to observe the pre-sorting microspheres, and the optical detection unit sends the observation results to the detection and sorting control unit. If the sorting If there is a defect in the front microsphere, the detection and sorting control unit sends an instruction to the signal generator, and the signal generator turns on the asymmetric electrode to generate an uneven electric field. The uneven electric field causes the defective microsphere to deviate. Enter the defective microsphere fluid flow channel;
如果所述分选前微球不存在缺陷,则不接通所述不对称电极,以便使合格微球进入合格微球流体流道;If there are no defects in the microspheres before sorting, the asymmetric electrode is not connected so that qualified microspheres enter the qualified microsphere fluid flow channel;
(3)采用分配发液系统将合格微球流体分装在孔板中,对分装在所述孔板中的合格微球添加培养液。(3) Use a liquid dispensing system to distribute the qualified microsphere fluid in the well plate, and add culture fluid to the qualified microspheres distributed in the well plate.
根据本公开实施例所述的全自动化体外器官微球制备、分选以及分配培养的方法,具有以上实施例所述的全自动化体外器官微球制备、分选以及分配培养系统的所有优点,在此不再赘述。The fully automated in vitro organ microsphere preparation, sorting and distribution culture method according to the embodiments of the present disclosure has all the advantages of the fully automated in vitro organ microsphere preparation, sorting and distribution culture system described in the above embodiments. This will not be described again.
本公开的附加方面和优点将在下面的描述中部分给出,部分将从下面的描述中变得明显,或通过本公开的实践了解到。Additional aspects and advantages of the disclosure will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the disclosure.
附图说明Description of the drawings
本公开的上述和/或附加的方面和优点从结合下面附图对实施例的描述中将变得明显和容易理解,其 中:The above and/or additional aspects and advantages of the present disclosure will become apparent and readily understood from the description of the embodiments taken in conjunction with the following drawings, in which middle:
图1显示了本公开实施例的全自动化体外器官微球制备、分选以及分配培养的总系统的示意图;Figure 1 shows a schematic diagram of the overall system for fully automated in vitro organ microsphere preparation, sorting and distribution culture according to an embodiment of the present disclosure;
图2显示了本公开实施例的微流控芯片的结构示意图;Figure 2 shows a schematic structural diagram of a microfluidic chip according to an embodiment of the present disclosure;
图3显示了本公开实施例的制备系统的结构示意图;Figure 3 shows a schematic structural diagram of a preparation system according to an embodiment of the present disclosure;
图4显示了本公开实施例的检测分选系统的结构示意图;Figure 4 shows a schematic structural diagram of a detection and sorting system according to an embodiment of the present disclosure;
图5显示了本公开实施例的分配发液系统的结构示意图;Figure 5 shows a schematic structural diagram of a hair liquid dispensing system according to an embodiment of the present disclosure;
图6显示了本公开实施例的制备双乳化核壳结构微球的原理示意图;Figure 6 shows a schematic diagram of the principle of preparing double emulsion core-shell structure microspheres according to an embodiment of the present disclosure;
图7显示了本公开实施例的制备单乳化核壳结构微球的原理示意图;Figure 7 shows a schematic diagram of the principle of preparing single emulsion core-shell structure microspheres according to an embodiment of the present disclosure;
图8显示了本公开实施例的制备双乳化核壳结构微球的示意图;Figure 8 shows a schematic diagram of preparing double emulsion core-shell structure microspheres according to an embodiment of the present disclosure;
图9显示了本公开实施例的不同尺寸大小的体外器官微球的示意图;Figure 9 shows a schematic diagram of in vitro organ microspheres of different sizes according to embodiments of the present disclosure;
图10显示了本公开实施例的移动单元的移动路径示意图;Figure 10 shows a schematic diagram of the movement path of the mobile unit according to the embodiment of the present disclosure;
图11显示了本公开实施例1的分选后的VOS死活细胞染色荧光图;Figure 11 shows the fluorescence image of VOS dead and alive cells stained after sorting in Example 1 of the present disclosure;
图12显示了本公开实施例1的分配至孔板中的matrigel微球示意图;Figure 12 shows a schematic diagram of matrigel microspheres distributed into well plates according to Example 1 of the present disclosure;
图13显示了本公开实施例1培养的VOS状态图;Figure 13 shows the VOS state diagram cultivated in Example 1 of the present disclosure;
图14显示了本公开实施例1与传统手动方法制备培养的VOS进行对比图;Figure 14 shows a comparison of Example 1 of the present disclosure and the traditional manual method of preparing cultured VOS;
图15显示了本公开实施例1与传统手动方法制备培养的VOS的生长曲线图;Figure 15 shows the growth curve of VOS prepared and cultured in Example 1 of the present disclosure and traditional manual methods;
图16显示了本公开实施例1培养的核壳结构VOS的荧光图。Figure 16 shows the fluorescence image of the core-shell structure VOS cultured in Example 1 of the present disclosure.
附图标记:
1000-制备系统,100-微流控芯片,1100-微球制备流道,1110-油相流道,1120-壳结构的细胞流体流
道,1130-核结构的细胞流体流道,1140-汇合流道,1150-微球流体流道,1160-细胞流体流道,1200-流速控制单元,1300-压力控制器,1400-隔膜泵,1500-第一储液装置,1600-第二储液装置,1700-第三储液装置;
2000-检测分选系统,2100-缺陷微球流体流道,2200-合格微球流体流道,2300-不对称电极,2400-
光学检测单元,2500-信号发生器,2600-检测分选控制单元;
3000-分配发液系统,3100-支撑板,3200-滑道,3300-Y方向滑轨,3400-X方向滑轨,3500-移动平
台,3600-第一立杆,3700-第一连接杆,3800-微球流体分配管,3810-分配头,3900-第二立杆,3910-第二连接杆,3920-培养液移液器,3921-移液枪头。
Reference signs:
1000-preparation system, 100-microfluidic chip, 1100-microsphere preparation flow channel, 1110-oil phase flow channel, 1120-shell structure cell fluid flow channel, 1130-core structure cell fluid flow channel, 1140-sink Combined flow channel, 1150-microsphere fluid flow channel, 1160-cell fluid flow channel, 1200-flow rate control unit, 1300-pressure controller, 1400-diaphragm pump, 1500-first liquid storage device, 1600-second liquid storage device , 1700-third liquid storage device;
2000-detection and sorting system, 2100-defective microsphere fluid flow channel, 2200-qualified microsphere fluid flow channel, 2300-asymmetric electrode, 2400-
Optical detection unit, 2500-signal generator, 2600-detection and sorting control unit;
3000-hair liquid distribution system, 3100-support plate, 3200-slide, 3300-Y direction slide rail, 3400-X direction slide rail, 3500-mobile platform, 3600-first vertical pole, 3700-first connecting rod, 3800-microsphere fluid distribution tube, 3810-distribution head, 3900-second vertical rod, 3910-second connecting rod, 3920-culture liquid pipette, 3921-pipettor head.
发明详细描述Detailed description of the invention
下面详细描述本公开的实施例。下面描述的实施例是示例性的,仅用于解释本公开,而不能理解为对本公开的限制。Embodiments of the present disclosure are described in detail below. The embodiments described below are illustrative and are only used to explain the present disclosure and are not to be construed as limitations of the present disclosure.
此外,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此,限定有“第一”、“第二”的特征可以明示或者隐含地包括至少一个该特征。在本公开的描述中,“多个”的含义是至少两个,例如两个,三个等,除非另有明确具体的限定。In addition, the terms “first” and “second” are used for descriptive purposes only and cannot be understood as indicating or implying relative importance or implicitly indicating the quantity of indicated technical features. Therefore, features defined as "first" and "second" may explicitly or implicitly include at least one of these features. In the description of the present disclosure, "plurality" means at least two, such as two, three, etc., unless otherwise expressly and specifically limited.
术语“中心”、“纵向”、“横向”、“长度”、“宽度”、“厚度”、“上”、“下”、“前”、“后”、“左”、“右”、“竖直”、“水平”、“顶”、“底”、“内”、“外”、“轴向”、“径向”、“周向”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本公开和简化描述,而不是指示或暗示所指的元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本公开的限制。The terms "center", "lengthwise", "crosswise", "length", "width", "thickness", "top", "bottom", "front", "back", "left", "right", " The orientation or positional relationships indicated by "vertical", "horizontal", "top", "bottom", "inner", "outer", "axial", "radial", "circumferential", etc. are based on those shown in the accompanying drawings. The orientations or positional relationships shown are only to facilitate the description of the present disclosure and simplify the description, but do not indicate or imply that the indicated elements must have specific orientations, be constructed and operated in specific orientations, and therefore cannot be understood as limiting the disclosure.
在本公开中,除非另有明确的规定和限定,“安装”、“相连”、“连接”、“固定”等术语应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或成一体;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通或两个元件的相互作用关系,除非另有明确的限定。对于本领域的普通技术人员而言,可以根据具体情况理解上述术语在本公开中的具体含义。In this disclosure, unless otherwise clearly stated and limited, terms such as "installation", "connection", "connection", and "fixing" should be understood in a broad sense. For example, it can be a fixed connection or a detachable connection. or integrated into one; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium; it can be an internal connection between two elements or an interactive relationship between two elements, unless otherwise specified limited. For those of ordinary skill in the art, the specific meanings of the above terms in this disclosure can be understood according to specific circumstances.
在本公开中,除非另有明确的规定和限定,第一特征在第二特征“上”或“下”可以是第一和第二特征直接接触,或第一和第二特征通过中间媒介间接接触。而且,第一特征在第二特征“之上”、“上方”和“上面”可是第一特征在第二特征正上方或斜上方,或仅仅表示第一特征水平高度高于第二特征。第一特征在 第二特征“之下”、“下方”和“下面”可以是第一特征在第二特征正下方或斜下方,或仅仅表示第一特征水平高度小于第二特征。In this disclosure, unless otherwise expressly stated and limited, a first feature being "on" or "below" a second feature may mean that the first and second features are in direct contact, or the first and second features may be in indirect contact through an intermediary. touch. Furthermore, the terms "above", "above" and "above" the first feature is above the second feature may mean that the first feature is directly above or diagonally above the second feature, or simply means that the first feature is higher in level than the second feature. The first characteristic is “Below”, “below” and “below” the second feature may mean that the first feature is directly below or diagonally below the second feature, or simply means that the first feature has a smaller horizontal height than the second feature.
在本公开的实施例中,针对现有制备方法制备的体外器官微球大小尺寸不均一且不可控问题,本公开利用微流控微液滴生成及凝胶固化技术实现了大小尺寸均一可控的体外器官微球的制备。针对现有方法无法对制备的VOS进行检测及分选问题,本公开在微流控芯片上结合光学检测单元及介电泳分选技术实现了VOS的有效分选功能,实现了VOS的自动化检测分选,为VOS的制备提供了有效的质控手段。针对现有分发手段为手动分发导致的效率低及准确率差等问题,本公开利用其移动路径可控制的移动单元实现体外器官微球的自动分配。针对现有培养方法无法满足自动化培养的需求,本公开基于培养液移液单元实现自动加液。针对现有制备系统庞大且无法在生物安全柜内操作问题,本公开通过集成隔膜泵及压力控制器、制冷模块、加热单元、移动单元、微球流体分配单元、培养液移液单元及检测分选系统,具有体积小、操作便捷、全自动化、易于推广等优势。针对现有制备方法中使用注射泵及注射器导致的加样繁琐且存在气泡等干扰因素,本公开基于隔膜泵驱动方式,一次加样后即可实现一键式操作。In the embodiments of the present disclosure, in order to solve the problem of uneven and uncontrollable sizes of in vitro organ microspheres prepared by existing preparation methods, the present disclosure uses microfluidic microdroplet generation and gel solidification technology to achieve uniform and controllable sizes. Preparation of in vitro organoid microspheres. In view of the problem that the prepared VOS cannot be detected and sorted by existing methods, the present disclosure combines an optical detection unit and dielectrophoretic sorting technology on a microfluidic chip to achieve an effective sorting function of VOS and realize automated detection and sorting of VOS. selection, providing an effective quality control method for the preparation of VOS. In view of the problems of low efficiency and poor accuracy caused by manual distribution in the existing distribution method, the present disclosure utilizes a mobile unit whose movement path is controllable to realize automatic distribution of organ microspheres outside the body. In view of the fact that existing culture methods cannot meet the needs of automated culture, the present disclosure implements automatic liquid addition based on a culture liquid pipetting unit. In view of the problem that the existing preparation system is bulky and cannot be operated in a biological safety cabinet, the present disclosure integrates a diaphragm pump and pressure controller, a refrigeration module, a heating unit, a mobile unit, a microsphere fluid distribution unit, a culture fluid pipetting unit and a detection analyzer. The selection system has the advantages of small size, convenient operation, full automation, and easy promotion. In view of the cumbersome sample addition caused by the use of syringe pumps and syringes in the existing preparation methods and the presence of interference factors such as bubbles, the present disclosure is based on a diaphragm pump driving method, which enables one-button operation after one sample addition.
有鉴于此,在本公开的一个方面,本公开提出了一种全自动化体外器官微球制备、分选以及分配培养的总系统,参考附图1,全自动化体外器官微球制备、分选以及分配培养的总系统包括:制备系统1000、检测分选系统2000和分配发液系统3000。In view of this, in one aspect of the present disclosure, the present disclosure proposes a fully automated overall system for the preparation, sorting and distribution of organ microspheres in vitro. With reference to Figure 1, the fully automated in vitro organ microsphere preparation, sorting and The total system for distributing culture includes: preparation system 1000, detection and sorting system 2000, and distribution system 3000.
根据本公开的实施例,所述制备系统1000用于制备体外器官微球,所述制备系统1000包括设置在微流控芯片100上的微球制备流道1100,所述微球制备流道1100包括微球流体流道1150。制备不同结构的微球,其对应的微球制备流道1100不同,具体来说:According to an embodiment of the present disclosure, the preparation system 1000 is used to prepare organ microspheres in vitro. The preparation system 1000 includes a microsphere preparation flow channel 1100 disposed on a microfluidic chip 100. The microsphere preparation flow channel 1100 Microsphere fluid flow channels 1150 are included. To prepare microspheres with different structures, the corresponding microsphere preparation flow channels 1100 are different, specifically:
当制备双乳化核壳结构的微球时,参考附图2和6,所述微球制备流道1100包括:壳结构的细胞流体流道1120、核结构的细胞流体流道1130和油相流道1110,壳结构的细胞流体流道1120内为壳结构的细胞流体,核结构的细胞流体流道1130内为核结构的细胞流体,油相流道1110内为油相。所述壳结构的细胞流体流道1120和所述核结构的细胞流体流道1130相汇合形成汇合流道1140,且在所述壳结构的细胞流体流道1120和所述核结构的细胞流体流道1130的汇合处,所述壳结构的细胞流体流道1120设置在所述核结构的细胞流体流道1130的两侧。在汇合流道1140内,壳结构的细胞流体和核结构的细胞流体并不相溶,而是形成依次包括壳结构的细胞流体、核结构的细胞流体和壳结构的细胞流体的三层层流,壳结构的细胞流体分布在核结构的细胞流体的两侧,由此使壳结构的细胞流体包裹在核结构的细胞流体的两侧,以便后续能形成核壳结构的微球。所述汇合流道1140与所述油相流道1110相汇合形成微球流体流道1150,在所述汇合流道1140与所述油相流道1110的汇合处,所述油相流道1110设置在所述汇合流道1140的两侧。在汇合处,上述依次包括壳结构的细胞流体、核结构的细胞流体和壳结构的细胞流体的三层层流被其两侧流入的油相剪切,从而形成核壳结构的微球,且使所述核壳结构体外器官微球包裹在所述油相中。该核壳结构体外器官微球的结构如附图8所示,其中图8a为核结构的示意图,图8b为壳结构的示意图,图8c为核壳结构的示意图。该核壳结构可实现VOS的血管化共培养,进一步提高VOS在性能上对体内器官的仿真度,为VOS作为体外模型应用于临床医学、精准医疗及药物筛选等领域奠定了基础,解决了目前的方法制备的VOS结构简单而无法形成血管结构或与免疫细胞共培养等问题。When preparing microspheres with a double emulsion core-shell structure, refer to Figures 2 and 6. The microsphere preparation flow channel 1100 includes: a cell fluid flow channel 1120 with a shell structure, a cell fluid flow channel 1130 with a core structure, and an oil phase flow. Channel 1110, the cell fluid channel 1120 of the shell structure contains the cell fluid of the shell structure, the cell fluid channel 1130 of the core structure contains the cell fluid of the core structure, and the oil phase channel 1110 contains the oil phase. The cell fluid flow channel 1120 of the shell structure and the cell fluid flow channel 1130 of the core structure merge to form a merged flow channel 1140, and between the cell fluid flow channel 1120 of the shell structure and the cell fluid flow channel 1130 of the core structure, At the confluence of the channels 1130, the cell fluid flow channel 1120 of the shell structure is disposed on both sides of the cell fluid flow channel 1130 of the core structure. In the converging flow channel 1140, the cellular fluid of the shell structure and the cellular fluid of the core structure do not dissolve, but form a three-layer laminar flow including the cellular fluid of the shell structure, the cellular fluid of the core structure, and the cellular fluid of the shell structure in sequence. , the cell fluid of the shell structure is distributed on both sides of the cell fluid of the core structure, so that the cell fluid of the shell structure is wrapped on both sides of the cell fluid of the core structure, so that microspheres of the core-shell structure can be formed later. The converging flow channel 1140 and the oil phase flow channel 1110 merge to form a microsphere fluid flow channel 1150. At the confluence of the converging flow channel 1140 and the oil phase flow channel 1110, the oil phase flow channel 1110 are provided on both sides of the converging flow channel 1140. At the confluence, the above-mentioned three-layer laminar flow including the cellular fluid of the shell structure, the cellular fluid of the core structure and the cellular fluid of the shell structure are sheared by the oil phase flowing in from both sides, thereby forming microspheres with a core-shell structure, and The core-shell structure in vitro organ microspheres are wrapped in the oil phase. The structure of the core-shell structure in vitro organ microsphere is shown in Figure 8, wherein Figure 8a is a schematic diagram of the core structure, Figure 8b is a schematic diagram of the shell structure, and Figure 8c is a schematic diagram of the core-shell structure. This core-shell structure can realize vascularized co-culture of VOS, further improve the performance of VOS to simulate the organs in the body, lay a foundation for the application of VOS as an in vitro model in the fields of clinical medicine, precision medicine and drug screening, and solve the current problems. The VOS prepared by this method has a simple structure and cannot form vascular structures or co-culture with immune cells.
根据本公开的实施例,上述壳结构的细胞流体流道1120的宽度以及壳结构的细胞流体流道1120内的壳结构的细胞流体的流速均不受特别限制,本领域人员可根据实际需求进行设计,作为一个优选的方案,所述壳结构的细胞流体流道1120的宽度为100~150μm,所述壳结构的细胞流体流道1120内的壳结构的细胞流体的流速为0.5~5μL/min。According to embodiments of the present disclosure, the width of the cell fluid flow channel 1120 of the shell structure and the flow rate of the cell fluid of the shell structure within the cell fluid flow channel 1120 of the shell structure are not particularly limited, and those in the art can proceed according to actual needs. Design, as a preferred solution, the width of the shell-structured cell fluid flow channel 1120 is 100-150 μm, and the flow rate of the shell-structured cell fluid in the shell-structured cell fluid flow channel 1120 is 0.5-5 μL/min. .
根据本公开的实施例,上述核结构的细胞流体流道1130的宽度以及核结构的细胞流体流道1130内的核结构的细胞流体的流速均不受特别限制,本领域人员可根据实际需求进行设计,作为一个优选的方案,所述核结构的细胞流体流道1130的宽度为100~150μm,所述核结构的细胞流体流道1130内的核结构的细胞流体的流速为0.5~5μL/min。According to embodiments of the present disclosure, the width of the cellular fluid flow channel 1130 of the nuclear structure and the flow rate of the cellular fluid of the nuclear structure within the cellular fluid channel 1130 of the nuclear structure are not particularly limited, and those in the art can proceed according to actual needs. Design, as a preferred solution, the width of the nuclear structure cell fluid channel 1130 is 100-150 μm, and the flow rate of the nuclear structure cell fluid in the nuclear structure cell fluid channel 1130 is 0.5-5 μL/min. .
根据本公开的实施例,上述油相流道1110的宽度以及油相内的油相的流速均不受特别限制,本领域人员可根据实际需求进行设计,作为一个优选的方案,所述油相流道1110的宽度为75~300μm,所述油相流道1110内的油相的流速为1~20μL/min。According to the embodiment of the present disclosure, the width of the oil phase flow channel 1110 and the flow rate of the oil phase in the oil phase are not particularly limited. Persons in the art can design according to actual needs. As a preferred solution, the oil phase The width of the flow channel 1110 is 75-300 μm, and the flow rate of the oil phase in the oil phase flow channel 1110 is 1-20 μL/min.
根据本公开的实施例,所述壳结构的细胞流体流道1120内的壳结构的细胞流体包括壳结构的细胞和 第一水凝胶,第一水凝胶作为壳结构的细胞的分散介质。所述核结构的细胞流体流道1130内的核结构的细胞流体包括核结构的细胞和第二水凝胶,第二水凝胶作为核结构的细胞的分散介质。所述壳结构的细胞与所述核结构的细胞不同,所述第一水凝胶和所述第二水凝胶不同,由此才能形成不相溶的多层层流。需要说明的是,上述壳结构的细胞的具体种类、核结构的细胞的具体种类、第一水凝胶的具体种类以及第二水凝胶的具体种类均不受特别限制,作为一个具体示例,所述壳结构的细胞选自脐带静脉内皮细胞和免疫细胞中的至少一种,所述核结构的细胞选自肿瘤细胞和干细胞中的至少一种,所述第一水凝胶选自纤维蛋白原、胶原和海藻酸盐中的至少一种,所述第二水凝胶选自基质胶、纤维蛋白原和胶原中的至少一种。According to an embodiment of the present disclosure, the cell fluid of the shell structure within the cell fluid channel 1120 of the shell structure includes cells of the shell structure and The first hydrogel serves as a dispersion medium for the cells of the shell structure. The cell fluid of the nuclear structure in the cell fluid channel 1130 of the nuclear structure includes the cells of the nuclear structure and a second hydrogel, and the second hydrogel serves as a dispersion medium for the cells of the nuclear structure. The cells of the shell structure are different from the cells of the core structure, and the first hydrogel and the second hydrogel are different, so that an incompatible multi-layer laminar flow can be formed. It should be noted that the specific types of cells with the shell structure, the specific types of cells with the core structure, the specific types of the first hydrogel, and the specific types of the second hydrogel are not particularly limited. As a specific example, The cells of the shell structure are selected from at least one of umbilical cord vein endothelial cells and immune cells, the cells of the nuclear structure are selected from at least one of tumor cells and stem cells, and the first hydrogel is selected from fibrin. The second hydrogel is at least one selected from the group consisting of Matrigel, fibrinogen and collagen.
根据本公开的一个具体实施例,参考附图3,所述制备系统1000还包括:第一储液装置1500,所述第一储液装置1500的出液口与所述壳结构的细胞流体流道1120的入口相连,所述第一储液装置1500用于储存壳结构的细胞流体;第二储液装置1600,所述第二储液装置1600的出液口与所述核结构的细胞流体流道1130的入口相连,所述第二储液装置1600用于储存核结构的细胞流体;第三储液装置1700,所述第三储液装置1700的出液口与所述油相流道1110的入口相连,所述第三储液装置1700用于储存油相。According to a specific embodiment of the present disclosure, with reference to Figure 3, the preparation system 1000 further includes: a first liquid storage device 1500, the liquid outlet of the first liquid storage device 1500 is connected with the cell fluid flow of the shell structure. The inlet of the channel 1120 is connected, and the first liquid storage device 1500 is used to store the cell fluid of the shell structure; the second liquid storage device 1600, the liquid outlet of the second liquid storage device 1600 is connected with the cell fluid of the core structure. The inlet of the flow channel 1130 is connected, the second liquid storage device 1600 is used to store the cellular fluid of the nuclear structure; the third liquid storage device 1700, the liquid outlet of the third liquid storage device 1700 is connected with the oil phase flow channel 1110 is connected to the inlet, and the third liquid storage device 1700 is used to store the oil phase.
进一步地,参考附图3,所述制备系统1000还包括:压力控制器1300和隔膜泵1400,所述压力控制器1300分别与所述第一储液装置1500、所述第二储液装置1600和所述第三储液装置1700相连,所述隔膜泵1400与所述压力控制器1300相连。具体地,隔膜泵1400连接压力控制器1300,压力控制器1300连接储液装置,储液装置通过管子连接压力控制器1300并通过伸入液面下的毛细管连接微流控芯片100。隔膜泵1400的作用是产生压力,压力控制器1300的作用是调节隔膜泵1400产生的压力,储液装置中的流体经压力控制器1300调节后的气压压出后进入微流控芯片100进行VOS制备。由此,通过调节压力控制器1300气压大小对各流道内流体的流速进行调控,从而实现对VOS的大小及间隔距离等参数进行调节;同时还解决了目前体外器官微球制备过程中的通量低、尺寸大小不均一且不可控以及依靠人工操作难实现标准化制备的问题。另外,在细胞或组织微块浓度一定的情况下,可进一步通过调控微球体积大小来决定其中细胞或组织微块的数量,如图9所示。Further, referring to Figure 3, the preparation system 1000 also includes: a pressure controller 1300 and a diaphragm pump 1400. The pressure controller 1300 is connected to the first liquid storage device 1500 and the second liquid storage device 1600 respectively. It is connected to the third liquid storage device 1700, and the diaphragm pump 1400 is connected to the pressure controller 1300. Specifically, the diaphragm pump 1400 is connected to the pressure controller 1300, and the pressure controller 1300 is connected to the liquid storage device. The liquid storage device is connected to the pressure controller 1300 through a tube and connected to the microfluidic chip 100 through a capillary tube extending under the liquid surface. The function of the diaphragm pump 1400 is to generate pressure, and the function of the pressure controller 1300 is to adjust the pressure generated by the diaphragm pump 1400. The fluid in the liquid storage device is pressed out by the air pressure adjusted by the pressure controller 1300 and then enters the microfluidic chip 100 for VOS. preparation. Thus, by adjusting the air pressure of the pressure controller 1300, the flow rate of the fluid in each channel is adjusted, thereby adjusting the size and spacing distance of VOS and other parameters; at the same time, it also solves the problem of flux in the current preparation process of organ microspheres in vitro The problem is that it is low, the size is uneven and uncontrollable, and it is difficult to achieve standardized preparation by relying on manual operations. In addition, when the concentration of cells or tissue micro-blocks is constant, the number of cells or tissue micro-blocks can be further determined by adjusting the volume of the microspheres, as shown in Figure 9.
进一步地,参考附图3,所述制备系统1000还包括:流速控制单元1200,所述流速控制单元1200与所述压力控制器1300相连,所述流速控制单元1200通过控制压力控制器1300控制储液装置中的气压从而达到控制流道内流体的流速的目的。上述流速控制单元1200可以是电子设备,例如可以是手机或者电脑等。Further, referring to Figure 3, the preparation system 1000 also includes: a flow rate control unit 1200, which is connected to the pressure controller 1300. The flow rate control unit 1200 controls the storage by controlling the pressure controller 1300. The air pressure in the liquid device is used to control the flow rate of the fluid in the flow channel. The flow rate control unit 1200 may be an electronic device, such as a mobile phone or a computer.
进一步地,所述制备系统1000还包括:制冷模块(在图中未示出),所述制冷模块用于将所述微流控芯片100、所述第一储液装置1500、所述第二储液装置1600和所述第三储液装置1700的温度维持在某一设定温度(例如4℃)。具体地,可将所述微流控芯片100设置在制冷模块(例如制冷板)上,在所述第一储液装置1500、所述第二储液装置1600和所述第三储液装置1700的外围包裹制冷模块。Further, the preparation system 1000 also includes: a refrigeration module (not shown in the figure), the refrigeration module is used to combine the microfluidic chip 100, the first liquid storage device 1500, the second liquid storage device 1500 and the second liquid storage device 1500. The temperatures of the liquid storage device 1600 and the third liquid storage device 1700 are maintained at a certain set temperature (for example, 4°C). Specifically, the microfluidic chip 100 can be disposed on a refrigeration module (such as a refrigeration plate), in the first liquid storage device 1500 , the second liquid storage device 1600 and the third liquid storage device 1700 The refrigeration module is wrapped around the outside.
进一步地,所述制备系统1000还包括:保温单元(在图中未示出),所述微流控芯片100、所述第一储液装置1500、所述第二储液装置1600和所述第三储液装置1700均设置在所述保温单元内,使所述微流控芯片100、所述第一储液装置1500、所述第二储液装置1600和所述第三储液装置1700均维持在低温状态(例如维持在4℃),避免基质胶凝固。Further, the preparation system 1000 also includes: a heat preservation unit (not shown in the figure), the microfluidic chip 100, the first liquid storage device 1500, the second liquid storage device 1600 and the The third liquid storage device 1700 is disposed in the heat preservation unit, so that the microfluidic chip 100 , the first liquid storage device 1500 , the second liquid storage device 1600 and the third liquid storage device 1700 All are maintained at a low temperature (for example, maintained at 4°C) to avoid Matrigel solidification.
当制备单乳化微球时,参考附图7,所述微球制备流道包括:细胞流体流道1160和油相流道1110,所述细胞流体流道1160和所述油相流道1110相汇合形成微球流体流道。油相作为连续相利用剪切力将细胞流体切断,形成油包水VOS。具体来说,油相可以从一侧将细胞流体切断,如附图7a所示;油相也可以分布在细胞流体的两侧,从而使细胞流体被其两侧流入的油相剪切,如附图7b所示,形成油包水VOS。When preparing single emulsion microspheres, refer to Figure 7. The microsphere preparation flow channel includes: cell fluid flow channel 1160 and oil phase flow channel 1110. The cell fluid flow channel 1160 and the oil phase flow channel 1110 are in phase. They merge to form a microsphere fluid flow channel. As a continuous phase, the oil phase uses shear force to cut off the cell fluid, forming water-in-oil VOS. Specifically, the oil phase can cut off the cell fluid from one side, as shown in Figure 7a; the oil phase can also be distributed on both sides of the cell fluid, so that the cell fluid is sheared by the oil phase flowing in from both sides, such as As shown in Figure 7b, water-in-oil VOS is formed.
需要说明的是,上述制备单乳化微球的制备系统1000也同样包括储存细胞流体的装置和储存油相的装置、压力控制器1300、隔膜泵1400、制冷模块、保温单元等,其连接方式以及作用与制备双乳化微球的制备系统1000的结构相同,在此不再赘述。It should be noted that the above-mentioned preparation system 1000 for preparing single emulsion microspheres also includes a device for storing cell fluid and a device for storing oil phase, a pressure controller 1300, a diaphragm pump 1400, a refrigeration module, a heat preservation unit, etc., and their connection methods are as follows: The function is the same as the structure of the preparation system 1000 for preparing double emulsified microspheres, and will not be described again here.
根据本公开的实施例,参考附图2和4,检测分选系统,所述检测分选系统包括由所述微球流体流道1150分岔形成的缺陷微球流体流道2100和合格微球流体流道2200,所述缺陷微球流体流道2100和 所述合格微球流体流道2200均设置在所述微流控芯片100上,即微球的制备流道和检测分选流道均设置在所述微流控芯片100上,集制备和检测于一体。所述微球流体流道在分岔前对应的微流控芯片100上设置不对称电极2300,且所述缺陷微球流体流道2100一侧对应的电极产生的电场大于所述合格微球流体流道2200一侧对应的电极产生的电场。所述检测分选系统还包括信号发生器2500、检测分选控制单元2600和光学检测单元2400,所述光学检测单元2400设置在所述微球流体流道在分岔前对应的微流控芯片100的上方,所述信号发生器2500分别与所述不对称电极2300和所述检测分选控制单元2600相连,所述检测分选控制单元2600分别与所述光学检测单元2400和所述信号发生器2500相连。According to an embodiment of the present disclosure, with reference to Figures 2 and 4, a detection and sorting system is provided. The detection and sorting system includes a defective microsphere fluid channel 2100 formed by the bifurcation of the microsphere fluid channel 1150 and qualified microspheres. fluid channel 2200, the defective microsphere fluid channel 2100 and The qualified microsphere fluid flow channels 2200 are all arranged on the microfluidic chip 100, that is, the preparation flow channels and detection and sorting flow channels of microspheres are both arranged on the microfluidic chip 100, integrating preparation and detection. In one. The microsphere fluid channel is provided with an asymmetric electrode 2300 on the corresponding microfluidic chip 100 before bifurcation, and the electric field generated by the corresponding electrode on one side of the defective microsphere fluid channel 2100 is greater than that of the qualified microsphere fluid. The electric field generated by the corresponding electrode on one side of the flow channel 2200. The detection and sorting system also includes a signal generator 2500, a detection and sorting control unit 2600 and an optical detection unit 2400. The optical detection unit 2400 is arranged on the corresponding microfluidic chip before the microsphere fluid channel bifurcates. Above 100, the signal generator 2500 is respectively connected to the asymmetric electrode 2300 and the detection and sorting control unit 2600. The detection and sorting control unit 2600 is respectively connected to the optical detection unit 2400 and the signal generator. 2500 is connected.
采用上述检测分选系统进行检测分选的过程如下:在所述分选前微球流体分岔前,采用光学检测单元2400(例如显微镜头)对分选前微球进行观测,例如同时对荧光及侧向光散射成像进行观测,所述光学检测单元2400将观测结果发送至检测分选控制单元2600,如果所述分选前微球存在缺陷,例如当捕捉到荧光信号和/或检测到空泡时,则所述检测分选控制单元2600向信号发生器2500发出指令,所述信号发生器2500则接通不对称电极2300,以便产生不均匀电场,所述不均匀电场使缺陷微球发生偏离进入缺陷微球流体流道2100;如果所述分选前微球不存在缺陷,则不接通所述不对称电极2300,以便使合格微球进入合格微球流体流道2200。由此,所述检测分选系统为自动化操作,同时采用了荧光及明场两种检测方式相结合的方式,不仅可以筛选死细胞或组织块同时也可以筛选出空泡,提高了检测效率及准确率。The process of detecting and sorting using the above detection and sorting system is as follows: before the pre-sorting microsphere fluid is bifurcated, an optical detection unit 2400 (such as a microscope lens) is used to observe the pre-sorting microspheres, such as simultaneously observing fluorescence. and side light scattering imaging for observation, and the optical detection unit 2400 sends the observation results to the detection and sorting control unit 2600. If the microspheres are defective before sorting, for example, when a fluorescence signal is captured and/or a void is detected, When soaking, the detection and sorting control unit 2600 issues an instruction to the signal generator 2500, and the signal generator 2500 turns on the asymmetric electrode 2300 to generate an uneven electric field. The uneven electric field causes the generation of defective microspheres. deviation into the defective microsphere fluid channel 2100; if there are no defects in the microspheres before sorting, the asymmetric electrode 2300 is not connected so that qualified microspheres enter the qualified microsphere fluid channel 2200. Therefore, the detection and sorting system is an automated operation and uses a combination of fluorescence and bright field detection methods. It can not only screen out dead cells or tissue blocks, but also screen out vacuoles, which improves detection efficiency and Accuracy.
由此,采用上述制备系统1000和检测分选系统相结合,即可实现高活性VOS的自动化标准化制备。Therefore, by combining the above preparation system 1000 with the detection and sorting system, the automated and standardized preparation of highly active VOS can be achieved.
需要说明的是,上述检测分选控制单元2600是电子设备,例如可以是手机或者电脑等。优选的,上述检测分选控制单元2600和上述流速控制单元可以在同一个电子设备上。It should be noted that the above-mentioned detection and sorting control unit 2600 is an electronic device, such as a mobile phone or a computer. Preferably, the above-mentioned detection and sorting control unit 2600 and the above-mentioned flow rate control unit may be on the same electronic device.
所述总系统还包括加热单元(在图中未示出),用于将合格微球形成固态(此时的分散介质油相仍然是液态),所述加热单元的一端与所述合格微球流体流道2200的出口相连。检测合格的VOS流体从合格微球流体流道2200的出口流出,进入加热单元,在加热单元的加热作用下(例如加热至25℃)使合格微球形成固态,然后随油相一起流入分配发液系统。The total system also includes a heating unit (not shown in the figure) for forming qualified microspheres into a solid state (the oil phase of the dispersion medium is still liquid at this time). One end of the heating unit is connected to the qualified microspheres. The outlets of the fluid flow channels 2200 are connected. The qualified VOS fluid flows out from the outlet of the qualified microsphere fluid channel 2200 and enters the heating unit. Under the heating effect of the heating unit (for example, heated to 25°C), the qualified microspheres form a solid state, and then flow into the distribution distribution together with the oil phase. liquid system.
根据本公开的实施例,所述分配发液系统用于将经过所述检测分选系统分选得到的合格微球流体分装在孔板中以及对分装在所述孔板中的合格微球添加培养液。参考附图5,所述分配发液系统3000包括:支撑板3100,所述支撑板3100上设有滑道3200;移动单元,所述移动单元包括移动平台3500、X方向滑轨3400和Y方向滑轨3300,所述Y方向滑轨3300垂直设置在所述滑道3200上,所述Y方向滑轨3300可在所述滑道3200上沿Y方向移动,所述X方向滑轨3400垂直设置在所述Y方向滑轨3300上,所述X方向滑轨3400可在所述Y方向滑轨3300上沿X方向移动,所述移动平台3500固定在所述X方向滑轨3400的上方;孔板(在图5中未示出),所述孔板设置在所述移动平台3500上,所述孔板上设有多个培养孔;微球流体分配单元,所述微球流体分配单元包括微球流体分配管3800、第一连接杆3700和第一立杆3600,所述第一立杆3600设置在所述支撑板3100上,所述微球流体分配管3800通过第一连接杆3700支撑在所述培养孔的上方,所述微球流体分配管3800包括分配头3810,所述分配头3810设置在所述微球流体分配管3800的下端,所述微球流体分配管3800的上端与所述加热单元的另一端相连;培养液移液单元,所述培养液移液单元包括所述培养液移液器3920、第二连接杆3910和第二立杆3900,所述第二立杆3900设置在所述支撑板3100上,所述培养液移液器3920通过第二连接杆3910支撑在所述培养孔的上方,所述培养液移液器3920底部设有多个移液枪头3921。进一步地,所述分配发液系统还包括:分配发液控制单元,所述分配发液控制单元分别与所述移动单元、所述微球流体分配单元和所述培养液移液单元相连,所述分配发液控制单元分别控制移动单元的移动路径、每个培养孔中分配的VOS数量以及每个培养孔中添加的培养液的量。According to an embodiment of the present disclosure, the hair liquid dispensing system is used to distribute the qualified microsphere fluid sorted by the detection and sorting system into the orifice plate and to distribute the qualified microsphere fluid packed in the orifice plate. Add culture medium to the ball. Referring to Figure 5, the hair liquid dispensing system 3000 includes: a support plate 3100, a slide 3200 is provided on the support plate 3100; a mobile unit, the mobile unit includes a mobile platform 3500, an X-direction slide rail 3400 and a Y-direction slide rail 3400. Slide rail 3300. The Y-direction slide rail 3300 is vertically disposed on the slideway 3200. The Y-direction slide rail 3300 can move along the Y-direction on the slideway 3200. The X-direction slide rail 3400 is vertically disposed. On the Y-direction slide rail 3300, the X-direction slide rail 3400 can move in the X-direction on the Y-direction slide rail 3300, and the mobile platform 3500 is fixed above the X-direction slide rail 3400; holes plate (not shown in Figure 5), the well plate is arranged on the mobile platform 3500, and a plurality of culture wells are provided on the well plate; a microsphere fluid distribution unit, the microsphere fluid distribution unit includes Microsphere fluid distribution tube 3800, first connecting rod 3700 and first vertical rod 3600. The first vertical rod 3600 is provided on the support plate 3100. The microsphere fluid distribution tube 3800 is supported by the first connecting rod 3700. Above the culture well, the microsphere fluid distribution tube 3800 includes a distribution head 3810. The distribution head 3810 is disposed at the lower end of the microsphere fluid distribution tube 3800. The upper end of the microsphere fluid distribution tube 3800 is connected to the upper end of the microsphere fluid distribution tube 3800. The other end of the heating unit is connected to a culture liquid pipetting unit, which includes the culture liquid pipette 3920, a second connecting rod 3910, and a second vertical rod 3900. The second vertical rod 3900 is arranged on the support plate 3100. The culture fluid pipette 3920 is supported above the culture hole through the second connecting rod 3910. The culture fluid pipette 3920 is provided with multiple pipetting tips at the bottom. 3921. Further, the hair liquid distribution system further includes: a hair liquid distribution control unit, which is respectively connected to the moving unit, the microsphere fluid distribution unit and the culture liquid pipetting unit, so The distribution liquid control unit respectively controls the moving path of the mobile unit, the number of VOS distributed in each culture well, and the amount of culture liquid added in each culture well.
具体地,加热固化后的VOS流体通过PTFE管连接到微球流体分配管3800,通过分配头将加热固化后的VOS流体按照实际需求分发至孔板的各个培养孔中,此种分配方式可避免由于分配头移动产生的震动导致微球流体分配管3800中的VOS出现多个粘结等情况,确保VOS分发的稳定性。微球流体分配管3800垂直向下且位置固定,由此可减少因为移动而造成VOS分发的不稳定影响。在分发过程中将孔板放置于移动平台3500上方,并通过使移动平台3500按照预先设置的路线进行移动,将固化后的VOS通过分配头流出至孔板的各个孔中。每个孔中的VOS数量可根据实际需求进行调节。 Specifically, the heated and solidified VOS fluid is connected to the microsphere fluid distribution tube 3800 through a PTFE tube, and the heated and solidified VOS fluid is distributed through the distribution head to each culture well of the well plate according to actual needs. This distribution method can avoid Due to the vibration caused by the movement of the distribution head, the VOS in the microsphere fluid distribution tube 3800 may be bonded in multiple ways, ensuring the stability of VOS distribution. The microsphere fluid distribution tube 3800 is vertically downward and has a fixed position, thereby reducing the unstable influence of VOS distribution due to movement. During the distribution process, the orifice plate is placed above the mobile platform 3500, and by moving the mobile platform 3500 according to a preset route, the cured VOS flows out into each hole of the orifice plate through the distribution head. The number of VOS in each hole can be adjusted according to actual needs.
具体地,移动单元可根据实际需求按照一定的路径运动,其中所述Y方向滑轨3300可在所述滑道上沿Y方向移动,从而控制移动平台3500在Y方向的移动,所述X方向滑轨3400可在所述Y方向滑轨3300上沿X方向移动,从而控制移动平台3500在X方向的移动,由此,保证每个需要的孔中都有分配到VOS,不需要中途进行换板操作。孔板的移动途径可通过分配发液控制单元进行设置,可根据孔板及测试需求进行个性化设置,确保分配的VOS可以满足后期实验的需求,图10为其中一种路径示意。Specifically, the mobile unit can move according to a certain path according to actual needs, wherein the Y-direction slide rail 3300 can move along the Y-direction on the slide, thereby controlling the movement of the mobile platform 3500 in the Y-direction, and the X-direction slide rail 3300 can move along the Y-direction. The rail 3400 can move along the X direction on the Y-direction slide rail 3300, thereby controlling the movement of the mobile platform 3500 in the X direction. This ensures that VOS is allocated to each required hole, and there is no need to change the plate midway. operate. The moving path of the well plate can be set by the distribution liquid control unit, and can be personalized according to the well plate and test requirements to ensure that the distributed VOS can meet the needs of later experiments. Figure 10 is a schematic diagram of one of the paths.
当孔板完成VOS的分发后,可控制培养液移液单元移动至孔板上方进行添加培养液。培养液移液器3920底部可连接不同规格及数量的移液枪头,将培养液移液器3920移至储液槽上方,移液枪头通过负压从培养液储液槽吸取一定量的培养基后,移动至孔板上方,释放负压使培养液流出至孔板中。其加液量以及培养液移液器3920底部连接的枪头数量及规格可根据使用的孔板规格进行匹配。自动加液在VOS分配结束后马上进行,避免基质胶脱水而导致细胞活性受到损伤。由此,所述分配发液系统为自动化操作。After the well plate completes the distribution of VOS, the culture liquid pipetting unit can be controlled to move to the top of the well plate to add culture liquid. The bottom of the culture medium pipette 3920 can be connected with pipette tips of different specifications and quantities. Move the culture medium pipette 3920 to the top of the liquid storage tank. The pipette head will draw a certain amount of liquid from the culture liquid storage tank through negative pressure. After adding culture medium, move to the top of the well plate and release the negative pressure to allow the culture medium to flow out into the well plate. The amount of liquid added and the number and specifications of the pipette tips connected to the bottom of the culture medium pipette 3920 can be matched according to the specifications of the well plate used. Automatic addition of liquid is performed immediately after VOS distribution to avoid damage to cell activity caused by Matrigel dehydration. Thus, the hair liquid dispensing system operates automatically.
进一步地,所述第一连接杆3700设置为可以所述第一立杆3600为轴周向转动,当微球流体分配管3800将加热成型后的微球流体分配完成后,可以第一立杆3600为轴周向转动第一连接杆3700,从而将微球流体分配管3800远离孔板的上方,避免影响后续培养液移液单元的操作。进一步地,所述第一立杆3600设置为可上下伸缩,由此,可实现第一立杆3600在Z轴上的移动,从而实现微球流体分配管3800在Z轴上的移动。Further, the first connecting rod 3700 is configured to rotate circumferentially with the first vertical rod 3600 as an axis. After the microsphere fluid distribution tube 3800 completes distributing the heated and formed microsphere fluid, the first vertical rod can be rotated. 3600 is a shaft that rotates the first connecting rod 3700 circumferentially to move the microsphere fluid distribution tube 3800 away from the top of the orifice plate to avoid affecting the subsequent operation of the culture fluid pipetting unit. Furthermore, the first vertical rod 3600 is configured to be telescopic up and down, thereby enabling the movement of the first vertical rod 3600 on the Z-axis, thereby realizing the movement of the microsphere fluid distribution tube 3800 on the Z-axis.
进一步地,所述第二立杆3900设置为可上下伸缩,可实现第二立杆3900在Z轴上的移动,从而实现培养液移液器3920在Z轴上的移动;另外,当微球流体分配单元分配加热成型后的微球流体时,将第二立杆3900升高,从而带动培养液移液器3920和第二连接杆升高,避免影响微球流体分配单元的分配操作;当微球流体分配单元的分配完成后,将第二立杆3900降低,从而带动培养液移液器3920和第二连接杆降低,使培养液移液器3920刚好处于培养孔的上方,对分装在所述孔板中的合格微球添加培养液。Further, the second vertical rod 3900 is configured to be telescopic up and down, which can realize the movement of the second vertical rod 3900 on the Z-axis, thereby realizing the movement of the culture medium pipette 3920 on the Z-axis; in addition, when the microsphere When the fluid distribution unit distributes the heated and formed microsphere fluid, the second vertical rod 3900 is raised, thereby driving the culture solution pipette 3920 and the second connecting rod to rise to avoid affecting the distribution operation of the microsphere fluid distribution unit; when After the distribution of the microsphere fluid distribution unit is completed, the second vertical rod 3900 is lowered, thereby driving the culture solution pipette 3920 and the second connecting rod to lower, so that the culture solution pipette 3920 is just above the culture well, and the dispensing Add culture fluid to the qualified microspheres in the well plate.
根据本公开实施例所述的全自动化体外器官微球制备、分选以及分配培养的总系统,解决了传统制备方法中存在的通量低、尺寸大小不均一且不可控,重现性差以及较难实现自动化制备及分配等问题,进而导致其在基础研究以及临床诊断等方面的应用受限。本公开基于微流控液滴生成及凝胶固化体系制备大小尺寸均一可控的VOS,并实现其自动化制备;同时在芯片上集成检测分选功能,对死细胞较多或无细胞的VOS进行了筛选,保证得到的VOS全部为高活性,实现目标VOS的有效分选;进一步利用微球流体分配单元和可控运动平台相配合实现VOS的自动化分配,解决了手动点样中的效率低及准确性差以及受操作人员影响极大等问题;最后利用培养液移液单元实现自动化的培养基或药物注入,减少操作过程中的污染隐患。本公开构建的模块化系统能够实现VOS的自动化制备和培养,操作简单且无污染,为药物筛选及药效评价提供重现性良好的体外生物模型,具有良好的应用前景及推广价值。同时,上述系统能大大节约原料及用药量,也能极大程度地降低成本及劳动量,提高药物筛选及新药研发的效率,具有极大的经济效益。According to the fully automated in vitro organ microsphere preparation, sorting and distribution culture system described in the embodiments of the present disclosure, the overall system solves the problems of low throughput, non-uniform and uncontrollable size, poor reproducibility and relatively large size in traditional preparation methods. It is difficult to achieve automated preparation and distribution, which in turn limits its application in basic research and clinical diagnosis. This disclosure uses a microfluidic droplet generation and gel solidification system to prepare VOS with uniform and controllable sizes, and realizes its automated preparation; at the same time, a detection and sorting function is integrated on the chip to detect VOS with a lot of dead cells or no cells. Screening is ensured to ensure that all the VOS obtained are highly active, achieving effective sorting of the target VOS; further utilizing the microsphere fluid distribution unit and the controllable motion platform to achieve automatic distribution of VOS, solving the low efficiency and low efficiency in manual spotting. Problems such as poor accuracy and great influence by the operator; finally, the culture medium pipetting unit is used to realize automated medium or drug injection to reduce the risk of contamination during the operation. The modular system constructed in this disclosure can realize the automated preparation and culture of VOS, is simple to operate and pollution-free, provides a reproducible in vitro biological model for drug screening and efficacy evaluation, and has good application prospects and promotion value. At the same time, the above-mentioned system can greatly save raw materials and dosage of drugs, greatly reduce costs and labor, and improve the efficiency of drug screening and new drug research and development, which has great economic benefits.
本公开另一方面提供一种采用以上实施例所述的总系统进行体外器官微球制备、分选以及分配培养的方法。根据本公开的实施例,所述方法包括:Another aspect of the present disclosure provides a method for in vitro organ microsphere preparation, sorting, and distribution culture using the overall system described in the above embodiments. According to an embodiment of the present disclosure, the method includes:
S100:在微球制备流道制备得到体外器官微球,所述体外器官微球包裹在油相中形成分选前微球流体,具体包括如下步骤:S100: Prepare in vitro organ microspheres in the microsphere preparation flow channel. The in vitro organ microspheres are wrapped in the oil phase to form pre-sorting microsphere fluid, which specifically includes the following steps:
S110:将壳结构的细胞流体通入壳结构的细胞流体流道1120,将核结构的细胞流体通入核结构的细胞流体流道1130,将油相通入油相流道1110;S110: Pass the cell fluid of the shell structure into the cell fluid channel 1120 of the shell structure, pass the cell fluid of the core structure into the cell fluid channel 1130 of the core structure, and pass the oil phase into the oil phase channel 1110;
S120:将所述壳结构的细胞流体和所述核结构的细胞流体汇合,形成汇合流体,且使所述壳结构的细胞流体分布在所述核结构的细胞流体的外侧;S120: Combine the cellular fluid of the shell structure and the cellular fluid of the core structure to form a merged fluid, and distribute the cellular fluid of the shell structure outside the cellular fluid of the core structure;
S130:将所述汇合流体与所述油相汇合,形成核壳结构体外器官微球,且使所述核壳结构体外器官微球包裹在所述油相中。S130: Combine the combined fluid and the oil phase to form core-shell structure extracorporeal organ microspheres, and wrap the core-shell structure extracorporeal organ microspheres in the oil phase.
S200:在所述分选前微球流体分岔前,采用光学检测单元对分选前微球进行观测,所述光学检测单元将观测结果发送至检测分选控制单元,如果所述分选前微球存在缺陷,则所述检测分选控制单元向信号发生器发出指令,所述信号发生器则接通不对称电极,以便产生不均匀电场,所述不均匀电场使缺陷 微球发生偏离进入缺陷微球流体流道2100;如果所述分选前微球不存在缺陷,则不接通所述不对称电极,以便使合格微球进入合格微球流体流道2200。S200: Before the pre-sorting microsphere fluid is bifurcated, an optical detection unit is used to observe the pre-sorting microspheres. The optical detection unit sends the observation results to the detection and sorting control unit. If the pre-sorting microsphere fluid is bifurcated, If there are defects in the microspheres, the detection and sorting control unit will issue instructions to the signal generator, and the signal generator will turn on the asymmetric electrode to generate an uneven electric field, and the uneven electric field will cause the defects to The microspheres deviate and enter the defective microsphere fluid channel 2100; if there are no defects in the microspheres before sorting, the asymmetric electrode is not connected so that qualified microspheres enter the qualified microsphere fluid channel 2200.
具体地,VOS流至分选区后可采用显微镜头同时对荧光及侧向光散射成像进行观测,并由电脑控制系统对观测结果进行分析,当捕捉到荧光信号时便向信号发生器发出指令,信号发生器则接通集成在芯片上的电极产生不均匀电场,使产生信号的VOS发生偏离进入缺陷微球流体流道2100中进行分离。同时进行侧向散射检测VOS的粒度的检测,当检测到空泡时触发信号发生器对该VOS进行分离,原理同上。通过双通道检测可达到同时分离低活度VOS及空泡,保证得到的VOS全部为高活性。此外,本公开方法提供的检测方法为对非目标VOS进行检测,即对低活度和空泡进行检测,鉴于目标VOS占生成的VOS的比重较大,且荧光染色剂对细胞活度易造成损害,因此,本方法选择对非目标VOS进行染色,避免了对标记对目标物带来的损伤,对高活度VOS具有保护效果,且分离效率更高。光学检测单元可同时对VOS进行荧光及侧面散射检测,并通过集成在芯片上的电极施加不对称电场使VOS发生偏移而达到分离的目的。Specifically, after VOS flows to the sorting area, a microscope lens can be used to observe fluorescence and side light scattering imaging at the same time, and the computer control system analyzes the observation results. When the fluorescence signal is captured, an instruction is issued to the signal generator. The signal generator connects the electrodes integrated on the chip to generate a non-uniform electric field, causing the VOS that generates the signal to deviate into the defective microsphere fluid channel 2100 for separation. At the same time, side scatter detection is performed to detect the particle size of VOS. When cavitation is detected, the signal generator is triggered to separate the VOS. The principle is the same as above. Dual-channel detection can simultaneously separate low-activity VOS and vacuoles, ensuring that all VOS obtained are highly active. In addition, the detection method provided by the disclosed method is to detect non-target VOS, that is, to detect low activity and vacuoles. In view of the fact that the target VOS accounts for a large proportion of the generated VOS, and the fluorescent dye can easily affect the cell activity. Therefore, this method chooses to stain non-target VOS, which avoids the damage caused by labeling to the target, has a protective effect on high-activity VOS, and has a higher separation efficiency. The optical detection unit can simultaneously detect fluorescence and side scattering of VOS, and apply an asymmetric electric field through electrodes integrated on the chip to shift the VOS to achieve separation.
而检测合格的VOS则继续通过芯片中流道从出口流出,随后通过25℃的加热板进行固化处理后进入分配发液系统。The VOS that has passed the test will continue to flow out from the outlet through the flow channel in the chip, and then pass through the 25°C heating plate for solidification treatment before entering the liquid distribution system.
S300:采用分配发液系统将合格微球流体分装在孔板中,对分装在所述孔板中的合格微球添加培养液。S300: Use a liquid dispensing system to distribute the qualified microsphere fluid in the well plate, and add culture fluid to the qualified microspheres distributed in the well plate.
具体地,加热固化后的VOS流体通过PTFE管连接到微球流体分配管,通过分配头将加热固化后的VOS流体按照实际需求分发至孔板的各个培养孔中。在分发过程中将孔板放置于移动平台上方,并通过使移动平台按照预先设置的路线进行移动,将固化后的VOS通过分配头流出至孔板的各个孔中。当孔板完成VOS的分发后,可控制培养液移液单元移动至孔板上方进行添加培养液。培养液移液器底部可连接不同规格及数量的移液枪头,将培养液移液器移至储液槽上方,移液枪头通过负压从培养液储液槽吸取一定量的培养基后,移动至孔板上方,释放负压使培养液流出至孔板中。其加液量以及培养液移液器底部连接的枪头数量及规格可根据使用的孔板规格进行匹配。自动加液在VOS分配结束后马上进行,避免基质胶脱水而导致细胞活性受到损伤。Specifically, the heated and solidified VOS fluid is connected to the microsphere fluid distribution tube through a PTFE tube, and the heated and solidified VOS fluid is distributed through the distribution head to each culture well of the well plate according to actual needs. During the distribution process, the orifice plate is placed above the moving platform, and the solidified VOS flows out through the distribution head into each hole of the orifice plate by making the moving platform move along a preset route. After the well plate completes the distribution of VOS, the culture liquid pipetting unit can be controlled to move to the top of the well plate to add culture liquid. The bottom of the culture medium pipette can be connected to pipette tips of different specifications and quantities. Move the culture medium pipette to the top of the liquid storage tank. The pipette head will draw a certain amount of culture medium from the culture liquid storage tank through negative pressure. Then, move to the top of the well plate and release the negative pressure to allow the culture medium to flow out into the well plate. The amount of liquid added and the number and specifications of the pipette tips connected to the bottom of the culture medium pipette can be matched according to the specifications of the well plate used. Automatic addition of liquid is performed immediately after VOS distribution to avoid damage to cell activity caused by Matrigel dehydration.
根据本公开实施例所述的全自动化体外器官微球制备、分选以及分配培养的方法,具有以上实施例所述的全自动化体外器官微球制备、分选以及分配培养系统的所有优点,在此不再赘述。The fully automated in vitro organ microsphere preparation, sorting and distribution culture method according to the embodiments of the present disclosure has all the advantages of the fully automated in vitro organ microsphere preparation, sorting and distribution culture system described in the above embodiments. This will not be described again.
实施例中未注明具体技术或条件的,按照本领域内的文献所描述的技术或条件或者按照产品说明书进行。所用试剂或仪器未注明生产厂商者,均为可以通过市购获得的常规产品。If specific techniques or conditions are not specified in the examples, the techniques or conditions described in literature in the field or product instructions will be followed. If the manufacturer of the reagents or instruments used is not indicated, they are all conventional products that can be purchased commercially.
实施例1Example 1
采用附图3和附图7所示的制备系统制备单乳化结构微球,方法如下:The preparation system shown in Figure 3 and Figure 7 is used to prepare microspheres with a single emulsion structure. The method is as follows:
在来自患者的肠肿瘤细胞中加入死细胞荧光染色剂,混合均匀后放置等待染色反应,反应结束后将染色好的细胞与matrigel混合均匀后加入储存装置中,将油相氟油HFE7000加入油相储存装置中,连接芯片。加样完成后对储液槽进行加压进样,打开隔膜泵,调节流量控制器,使细胞液的压力为15mbar,油相压力为25mbar,从而制备得到单乳化结构微球。Add the dead cell fluorescent dye to the intestinal tumor cells from the patient, mix them evenly and wait for the staining reaction. After the reaction, mix the stained cells with matrigel evenly and add it to the storage device. Add the oil phase fluorine oil HFE7000 to the oil phase. In the storage device, connect the chip. After the sample addition is completed, pressurize the liquid storage tank and inject the sample, turn on the diaphragm pump, and adjust the flow controller so that the pressure of the cell liquid is 15 mbar and the pressure of the oil phase is 25 mbar, thereby preparing microspheres with a single emulsion structure.
采用附图2和4所述的检测分选系统对上述制备得到备单乳化微球进行筛选,将出现红色荧光的微球或者空泡的微球筛选出来流入缺陷微球流体流道,而活性较高的微球流入合格微球流体流道,分选后的VOS再次进行死活细胞染色荧光显示如附图11所示,该荧光图中全是绿色(即图中白色点或灰色点为绿色荧光),没有红色,说明分选后的VOS的活性较高。The detection and sorting system described in Figures 2 and 4 is used to screen the preparation emulsified microspheres prepared above, and the microspheres with red fluorescence or vacuoles are screened out and flow into the defective microsphere fluid channel, and the active The higher microspheres flow into the qualified microsphere fluid channel, and the sorted VOS is stained for dead and alive cells again. The fluorescence display is shown in Figure 11. The fluorescence picture is all green (that is, the white points or gray points in the picture are green Fluorescence), there is no red color, indicating that the activity of VOS after sorting is higher.
检测合格的VOS流体从合格微球流体流道的出口流出,进入加热单元,在加热单元的加热作用下(25℃)使合格微球形成固态,然后随油相一起流入分配发液系统。采用附图5所述的检测分选系统自动将合格微球流体分配到384孔板中的各个培养孔中,如附图12所示。然后采用培养液移液单元向各个培养孔中添加培养基,最后放入细胞培养箱中进行培养。每天对VOS进行拍照观察,如附图13所述,从附图13中可以看出,各微球大小均一。同时与传统手动方法制备培养的VOS进行对比,结果如图14所示。绘制生长曲线,如附图15所示,从图14和15中可以看出,本实施例制备培养的VOS培养5天后可以观察到器官微球体积明显变大,与传统手动制备培养的VOS相比生长速度更快。 The qualified VOS fluid flows out from the outlet of the qualified microsphere fluid channel and enters the heating unit. Under the heating effect of the heating unit (25°C), the qualified microspheres form a solid state, and then flow into the hair liquid distribution system together with the oil phase. The detection and sorting system described in Figure 5 is used to automatically distribute the qualified microsphere fluid to each culture well in the 384-well plate, as shown in Figure 12. Then use a culture medium pipetting unit to add culture medium to each culture well, and finally put it into a cell culture incubator for culture. VOS was photographed and observed every day, as shown in Figure 13. It can be seen from Figure 13 that the size of each microsphere is uniform. At the same time, it was compared with the VOS prepared and cultured by traditional manual methods. The results are shown in Figure 14. Draw a growth curve, as shown in Figure 15. It can be seen from Figures 14 and 15 that after 5 days of culture, the volume of organ microspheres can be observed to be significantly larger in the VOS prepared and cultured in this embodiment, which is comparable to the VOS prepared and cultured by traditional manual methods. faster than the growth rate.
实施例2Example 2
采用附图2和附图3所示的制备系统制备双乳化核壳结构微球,方法如下:Double emulsion core-shell structure microspheres are prepared using the preparation system shown in Figure 2 and Figure 3. The method is as follows:
对核层来自患者的肠肿瘤细胞进行带GFP报告基因的病毒转染后与matrigel混合均匀后加入核层细胞液储存装置中,对壳层人脐静脉内皮细胞进行带RFP报告基因的病毒转染后与胶原蛋白混合均匀后加入壳层细胞液储存装置中,将油相氟油HFE7000加入油相储存装置中,连接芯片。加样完成后对储液槽进行加压进样,打开隔膜泵,调节流量控制器,使核层细胞液的压力为15mbar,壳层细胞液的压力为15mbar,油相压力为25mbar,从而制备得到备双乳化核壳结构微球。The intestinal tumor cells in the nuclear layer from the patient were transfected with a virus carrying the GFP reporter gene, and then mixed with matrigel evenly and then added to the nuclear layer cell fluid storage device. The human umbilical vein endothelial cells in the shell layer were transfected with a virus carrying the RFP reporter gene. Then mix it evenly with collagen and add it to the shell cell liquid storage device. Add the oil phase fluorine oil HFE7000 to the oil phase storage device and connect the chip. After the sample addition is completed, pressurize the liquid storage tank and inject the sample, turn on the diaphragm pump, and adjust the flow controller so that the pressure of the nuclear layer cell fluid is 15 mbar, the pressure of the shell layer cell fluid is 15 mbar, and the oil phase pressure is 25 mbar, thus preparing Microspheres with double emulsified core-shell structure were obtained.
将上述双乳化核壳结构微球分配到384孔板中的各个培养孔中。然后采用培养液移液单元向各个培养孔中添加培养基,最后放入细胞培养箱中进行培养。The above-mentioned double emulsion core-shell structure microspheres were distributed into each culture well in a 384-well plate. Then use a culture medium pipetting unit to add culture medium to each culture well, and finally put it into a cell culture incubator for culture.
然后通过荧光显微镜观察,并收集图像,结果如附图16所示,从附图16中可以看出,中间核层细胞为来自患者的肠肿瘤细胞,荧光染色呈绿色,外层壳为人脐静脉内皮细胞形成的血管结构,荧光染色呈红色,红色分布在外圈层(如B所示),绿色分布在中间层(如A所示),因此可证明本方法制备的VOS为核壳结构。同时从图16中还可以看出,该VOS具有血管结构(如C所示)。Then observe through a fluorescence microscope and collect images. The results are shown in Figure 16. It can be seen from Figure 16 that the cells in the middle nuclear layer are intestinal tumor cells from the patient. The fluorescent staining is green, and the outer shell is human umbilical vein. The vascular structure formed by endothelial cells is fluorescently stained red, with red distributed in the outer layer (as shown in B) and green in the middle layer (as shown in A). Therefore, it can be proved that the VOS prepared by this method has a core-shell structure. At the same time, it can also be seen from Figure 16 that the VOS has a vascular structure (as shown in C).
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本公开的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不必须针对的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任一个或多个实施例或示例中以合适的方式结合。此外,在不相互矛盾的情况下,本领域的技术人员可以将本说明书中描述的不同实施例或示例以及不同实施例或示例的特征进行结合和组合。In the description of this specification, reference to the terms "one embodiment," "some embodiments," "an example," "specific examples," or "some examples" or the like means that specific features are described in connection with the embodiment or example. , structures, materials, or features are included in at least one embodiment or example of the present disclosure. In this specification, the schematic expressions of the above terms are not necessarily directed to the same embodiment or example. Furthermore, the specific features, structures, materials or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Furthermore, those skilled in the art may combine and combine different embodiments or examples and features of different embodiments or examples described in this specification unless they are inconsistent with each other.
尽管上面已经示出和描述了本公开的实施例,可以理解的是,上述实施例是示例性的,不能理解为对本公开的限制,本领域的普通技术人员在本公开的范围内可以对上述实施例进行变化、修改、替换和变型。 Although the embodiments of the present disclosure have been shown and described above, it can be understood that the above-mentioned embodiments are illustrative and should not be construed as limitations of the present disclosure. Those of ordinary skill in the art can make modifications to the above-mentioned embodiments within the scope of the present disclosure. The embodiments are subject to changes, modifications, substitutions and variations.

Claims (15)

  1. 一种全自动化体外器官微球制备、分选以及分配培养的总系统,其中,包括:A fully automated total system for in vitro organ microsphere preparation, sorting and distribution culture, including:
    制备系统,所述制备系统用于制备体外器官微球,所述制备系统包括设置在微流控芯片上的微球制备流道,所述微球制备流道包括微球流体流道;Preparation system, the preparation system is used to prepare in vitro organ microspheres, the preparation system includes a microsphere preparation flow channel provided on a microfluidic chip, the microsphere preparation flow channel includes a microsphere fluid flow channel;
    检测分选系统,所述检测分选系统包括由所述微球流体流道分岔形成的缺陷微球流体流道和合格微球流体流道,所述缺陷微球流体流道和所述合格微球流体流道均设置在所述微流控芯片上,所述微球流体流道在分岔前对应的微流控芯片上设置不对称电极,且所述缺陷微球流体流道一侧对应的电极产生的电场大于所述合格微球流体流道一侧对应的电极产生的电场,所述检测分选系统还包括信号发生器、检测分选控制单元和光学检测单元,所述光学检测单元设置在所述微球流体流道在分岔前对应的微流控芯片的上方,所述信号发生器分别与所述不对称电极和所述检测分选控制单元相连,所述检测分选控制单元分别与所述光学检测单元和所述信号发生器相连;Detection and sorting system, the detection and sorting system includes a defective microsphere fluid channel and a qualified microsphere fluid channel formed by the bifurcation of the microsphere fluid channel, the defective microsphere fluid channel and the qualified microsphere fluid channel The microsphere fluid channels are all arranged on the microfluidic chip. The microsphere fluid channels are provided with asymmetric electrodes on the corresponding microfluidic chip before bifurcation, and one side of the defective microsphere fluid channel The electric field generated by the corresponding electrode is greater than the electric field generated by the corresponding electrode on one side of the qualified microsphere fluid channel. The detection and sorting system also includes a signal generator, a detection and sorting control unit and an optical detection unit. The optical detection unit The unit is arranged above the microfluidic chip corresponding to the microsphere fluid channel before bifurcation, and the signal generator is connected to the asymmetric electrode and the detection and sorting control unit respectively, and the detection and sorting control unit The control unit is connected to the optical detection unit and the signal generator respectively;
    分配发液系统,所述分配发液系统用于将经过所述检测分选系统分选得到的合格微球流体分装在孔板中以及对分装在所述孔板中的合格微球添加培养液。Dispensing hair liquid system, the hair liquid distributing system is used for distributing the qualified microsphere fluid sorted by the detection and sorting system into the orifice plate and adding the qualified microsphere fluid packed in the orifice plate. Culture fluid.
  2. 根据权利要求1所述的总系统,其中,所述微球制备流道包括:壳结构的细胞流体流道、核结构的细胞流体流道和油相流道,所述壳结构的细胞流体流道和所述核结构的细胞流体流道相汇合形成汇合流道,所述汇合流道与所述油相流道相汇合形成所述微球流体流道,在所述壳结构的细胞流体流道和所述核结构的细胞流体流道的汇合处,所述壳结构的细胞流体流道设置在所述核结构的细胞流体流道的两侧,在所述汇合流道与所述油相流道的汇合处,所述油相流道设置在所述汇合流道的两侧。The total system according to claim 1, wherein the microsphere preparation flow channel includes: a cell fluid flow channel with a shell structure, a cell fluid flow channel with a core structure, and an oil phase flow channel, and the cell fluid flow channel with the shell structure The channel and the cell fluid flow channel of the core structure merge to form a merged flow channel, and the merged flow channel merges with the oil phase flow channel to form the microsphere fluid flow channel. In the cell fluid flow channel of the shell structure, The confluence of the channel and the cell fluid flow channel of the core structure. The cell fluid flow channel of the shell structure is arranged on both sides of the cell fluid flow channel of the core structure. Between the confluence channel and the oil phase At the confluence of flow channels, the oil phase flow channels are arranged on both sides of the merged flow channels.
  3. 根据权利要求2所述的总系统,其中,所述制备系统还包括:The total system of claim 2, wherein the preparation system further includes:
    第一储液装置,所述第一储液装置的出液口与所述壳结构的细胞流体流道的入口相连,所述第一储液装置用于储存壳结构的细胞流体;A first liquid storage device, the liquid outlet of the first liquid storage device is connected to the inlet of the cell fluid flow channel of the shell structure, and the first liquid storage device is used to store the cell fluid of the shell structure;
    第二储液装置,所述第二储液装置的出液口与所述核结构的细胞流体流道的入口相连,所述第二储液装置用于储存核结构的细胞流体;a second liquid storage device, the liquid outlet of the second liquid storage device is connected to the inlet of the cell fluid flow channel of the nuclear structure, and the second liquid storage device is used to store the cell fluid of the nuclear structure;
    第三储液装置,所述第三储液装置的出液口与所述油相流道的入口相连,所述第三储液装置用于储存油相;A third liquid storage device, the liquid outlet of the third liquid storage device is connected to the inlet of the oil phase flow channel, and the third liquid storage device is used to store the oil phase;
    压力控制器和隔膜泵,所述压力控制器分别与所述第一储液装置、所述第二储液装置和所述第三储液装置相连,所述隔膜泵与所述压力控制器相连。A pressure controller and a diaphragm pump. The pressure controller is connected to the first liquid storage device, the second liquid storage device and the third liquid storage device respectively. The diaphragm pump is connected to the pressure controller. .
  4. 根据权利要求3所述的总系统,其中,所述制备系统还包括:流速控制单元,所述流速控制单元与所述压力控制器相连。The overall system according to claim 3, wherein the preparation system further includes: a flow rate control unit, the flow rate control unit is connected to the pressure controller.
  5. 根据权利要求3或4所述的总系统,其中,所述制备系统还包括:The total system according to claim 3 or 4, wherein the preparation system further includes:
    制冷模块,所述制冷模块用于将所述微流控芯片、所述第一储液装置、所述第二储液装置和所述第三储液装置的温度维持在某一设定温度。A refrigeration module, the refrigeration module is used to maintain the temperatures of the microfluidic chip, the first liquid storage device, the second liquid storage device and the third liquid storage device at a certain set temperature.
  6. 根据权利要求3或4所述的总系统,其中,所述制备系统还包括:The total system according to claim 3 or 4, wherein the preparation system further includes:
    保温单元,所述微流控芯片、所述第一储液装置、所述第二储液装置和所述第三储液装置均设置在所述保温单元内。The heat preservation unit, the microfluidic chip, the first liquid storage device, the second liquid storage device and the third liquid storage device are all arranged in the heat preservation unit.
  7. 根据权利要求2所述的总系统,其中,所述壳结构的细胞流体流道的宽度为100~150μm,所述壳结构的细胞流体流道内的壳结构的细胞流体的流速为0.5~5μL/min。The total system according to claim 2, wherein the width of the cell fluid channel of the shell structure is 100-150 μm, and the flow rate of the cell fluid of the shell structure in the cell fluid channel of the shell structure is 0.5-5 μL/ min.
  8. 根据权利要求2所述的总系统,其中,所述核结构的细胞流体流道的宽度为100~150μm,所述核结构的细胞流体流道内的核结构的细胞流体的流速为0.5~5μL/min。The total system according to claim 2, wherein the width of the cellular fluid channel of the nuclear structure is 100-150 μm, and the flow rate of the cellular fluid of the nuclear structure in the cellular fluid channel of the nuclear structure is 0.5-5 μL/ min.
  9. 根据权利要求2所述的总系统,其中,所述油相流道的宽度为75~300μm,所述油相流道内的油相的流速为1~20μL/min。The total system according to claim 2, wherein the width of the oil phase flow channel is 75-300 μm, and the flow rate of the oil phase in the oil phase flow channel is 1-20 μL/min.
  10. 根据权利要求2所述的总系统,其中,所述壳结构的细胞流体流道内的壳结构的细胞流体包括壳结构的细胞和第一水凝胶,所述核结构的细胞流体流道内的核结构的细胞流体包括核结构的细胞和第二水凝胶,所述壳结构的细胞与所述核结构的细胞不同,所述第一水凝胶和所述第二水凝胶不同,所述壳结构的细胞选自脐带静脉内皮细胞和免疫细胞中的至少一种,所述核结构的细胞选自肿瘤细胞和干细胞中的至少一种,所述第一水凝胶选自纤维蛋白原、胶原和海藻酸盐中的至少一种,所述第二水凝胶选 自基质胶、纤维蛋白原和胶原中的至少一种。The total system of claim 2, wherein the cell fluid of the shell structure within the cell fluid flow channel of the shell structure includes cells of the shell structure and a first hydrogel, and the core within the cell fluid flow channel of the core structure The cellular fluid of the structure includes cells of a core structure and a second hydrogel, the cells of the shell structure are different from the cells of the core structure, the first hydrogel and the second hydrogel are different, the The cells of the shell structure are selected from at least one of umbilical cord vein endothelial cells and immune cells, the cells of the nuclear structure are selected from at least one of tumor cells and stem cells, and the first hydrogel is selected from fibrinogen, At least one of collagen and alginate, the second hydrogel is selected from At least one of Matrigel, fibrinogen and collagen.
  11. 根据权利要求1所述的总系统,其中,所述微球制备流道包括:细胞流体流道和油相流道,所述细胞流体流道和所述油相流道相汇合形成微球流体流道。The total system according to claim 1, wherein the microsphere preparation flow channel includes: a cell fluid flow channel and an oil phase flow channel, and the cell fluid flow channel and the oil phase flow channel merge to form a microsphere fluid flow channel.
  12. 根据权利要求1所述的总系统,其中,所述总系统还包括加热单元,用于将合格微球形成固态,所述加热单元的一端与所述合格微球流体流道的出口相连;The total system according to claim 1, wherein the total system further includes a heating unit for forming qualified microspheres into a solid state, and one end of the heating unit is connected to the outlet of the qualified microsphere fluid flow channel;
    所述分配发液系统包括:The hair liquid dispensing system includes:
    支撑板,所述支撑板上设有滑道;A support plate, the support plate is provided with a slideway;
    移动单元,所述移动单元包括移动平台、X方向滑轨和Y方向滑轨,所述Y方向滑轨垂直设置在所述滑道上,所述Y方向滑轨可在所述滑道上沿Y方向移动,所述X方向滑轨垂直设置在所述Y方向滑轨上,所述X方向滑轨可在所述Y方向滑轨上沿X方向移动,所述移动平台固定在所述X方向滑轨的上方;Mobile unit, the mobile unit includes a mobile platform, an X-direction slide rail and a Y-direction slide rail. The Y-direction slide rail is vertically arranged on the slide rail. The Y-direction slide rail can move along the Y-direction on the slide rail. move, the X-direction slide rail is vertically arranged on the Y-direction slide rail, the X-direction slide rail can move along the X-direction on the Y-direction slide rail, and the mobile platform is fixed on the X-direction slide rail. above the rail;
    孔板,所述孔板设置在所述移动平台上,所述孔板上设有多个培养孔;A well plate, the well plate is arranged on the mobile platform, and the well plate is provided with a plurality of culture wells;
    微球流体分配单元,所述微球流体分配单元包括微球流体分配管、第一连接杆和第一立杆,所述第一立杆设置在所述支撑板上,所述微球流体分配管通过第一连接杆支撑在所述培养孔的上方,所述微球流体分配管包括分配头,所述分配头设置在所述微球流体分配管的下端,所述微球流体分配管的上端与所述加热单元的另一端相连;Microsphere fluid distribution unit, the microsphere fluid distribution unit includes a microsphere fluid distribution tube, a first connecting rod and a first vertical rod, the first vertical rod is arranged on the support plate, the microsphere fluid distribution unit The pipe is supported above the culture hole through a first connecting rod. The microsphere fluid distribution tube includes a distribution head. The distribution head is provided at the lower end of the microsphere fluid distribution tube. The microsphere fluid distribution tube has The upper end is connected to the other end of the heating unit;
    培养液移液单元,所述培养液移液单元包括所述培养液移液器、第二连接杆和第二立杆,所述第二立杆设置在所述支撑板上,所述培养液移液器通过第二连接杆支撑在所述培养孔的上方,所述培养液移液器底部设有多个移液枪头。Culture liquid pipetting unit, the culture liquid pipetting unit includes the culture liquid pipette, a second connecting rod and a second vertical rod, the second vertical rod is arranged on the support plate, the culture liquid pipetting unit The pipette is supported above the culture hole through a second connecting rod, and a plurality of pipette tips are provided at the bottom of the culture liquid pipette.
  13. 根据权利要求12所述的总系统,其中,所述分配发液系统还包括:分配发液控制单元,所述分配发液控制单元分别与所述移动单元、所述微球流体分配单元和所述培养液移液单元相连。The total system according to claim 12, wherein the hair liquid dispensing system further includes: a hair liquid distributing control unit, the hair liquid distributing control unit is connected to the moving unit, the microsphere fluid dispensing unit and the hair liquid distributing unit respectively. The culture medium pipetting unit is connected.
  14. 根据权利要求12所述的总系统,其中,所述第一连接杆设置为可以所述第一立杆为轴周向转动,所述第一立杆设置为可上下伸缩,所述第二立杆设置为可上下伸缩。The total system according to claim 12, wherein the first connecting rod is configured to rotate circumferentially about the axis of the first vertical rod, the first vertical rod is configured to be telescopic up and down, and the second vertical rod is configured to be telescopic up and down. The pole is configured to telescope up and down.
  15. 一种采用权利要求1-14任一项所述的总系统进行体外器官微球制备、分选以及分配培养的方法,其中,包括:A method for preparing, sorting, and distributing culture of organ microspheres in vitro using the total system according to any one of claims 1 to 14, which includes:
    (1)在微球制备流道制备得到体外器官微球,所述体外器官微球包裹在油相中形成分选前微球流体;(1) In vitro organ microspheres are prepared in the microsphere preparation flow channel, and the in vitro organ microspheres are wrapped in an oil phase to form a pre-sorting microsphere fluid;
    (2)在所述分选前微球流体分岔前,采用光学检测单元对分选前微球进行观测,所述光学检测单元将观测结果发送至检测分选控制单元,如果所述分选前微球存在缺陷,则所述检测分选控制单元向信号发生器发出指令,所述信号发生器则接通不对称电极,以便产生不均匀电场,所述不均匀电场使缺陷微球发生偏离进入缺陷微球流体流道;(2) Before the pre-sorting microsphere fluid bifurcates, an optical detection unit is used to observe the pre-sorting microspheres, and the optical detection unit sends the observation results to the detection and sorting control unit. If the sorting If there is a defect in the front microsphere, the detection and sorting control unit sends an instruction to the signal generator, and the signal generator turns on the asymmetric electrode to generate an uneven electric field. The uneven electric field causes the defective microsphere to deviate. Enter the defective microsphere fluid flow channel;
    如果所述分选前微球不存在缺陷,则不接通所述不对称电极,以便使合格微球进入合格微球流体流道;If there are no defects in the microspheres before sorting, the asymmetric electrode is not connected so that qualified microspheres enter the qualified microsphere fluid flow channel;
    (3)采用分配发液系统将合格微球流体分装在孔板中,对分装在所述孔板中的合格微球添加培养液。 (3) Use a liquid dispensing system to distribute the qualified microsphere fluid in the well plate, and add culture fluid to the qualified microspheres distributed in the well plate.
PCT/CN2023/110588 2022-08-02 2023-08-01 Total system and method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microsphere WO2024027717A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202210919531.5A CN115369033A (en) 2022-08-02 2022-08-02 Total system and method for full-automatic in-vitro organ microsphere preparation, sorting and distribution culture
CN202210919531.5 2022-08-02

Publications (1)

Publication Number Publication Date
WO2024027717A1 true WO2024027717A1 (en) 2024-02-08

Family

ID=84063909

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/110588 WO2024027717A1 (en) 2022-08-02 2023-08-01 Total system and method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microsphere

Country Status (2)

Country Link
CN (1) CN115369033A (en)
WO (1) WO2024027717A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115369033A (en) * 2022-08-02 2022-11-22 丹望医疗科技(上海)有限公司 Total system and method for full-automatic in-vitro organ microsphere preparation, sorting and distribution culture

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943475A (en) * 2019-04-12 2019-06-28 广西医科大学第一附属医院 The micro-fluidic sorting chip of one kind and its separation system
CN115369033A (en) * 2022-08-02 2022-11-22 丹望医疗科技(上海)有限公司 Total system and method for full-automatic in-vitro organ microsphere preparation, sorting and distribution culture
CN116103148A (en) * 2022-08-02 2023-05-12 丹望医疗科技(上海)有限公司 Preparation system and preparation method of core-shell structure external organ microsphere and total system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109943475A (en) * 2019-04-12 2019-06-28 广西医科大学第一附属医院 The micro-fluidic sorting chip of one kind and its separation system
CN115369033A (en) * 2022-08-02 2022-11-22 丹望医疗科技(上海)有限公司 Total system and method for full-automatic in-vitro organ microsphere preparation, sorting and distribution culture
CN116103148A (en) * 2022-08-02 2023-05-12 丹望医疗科技(上海)有限公司 Preparation system and preparation method of core-shell structure external organ microsphere and total system

Also Published As

Publication number Publication date
CN115369033A (en) 2022-11-22

Similar Documents

Publication Publication Date Title
KR101401199B1 (en) Device and Method of Generating In Vitro Blood Vessels
US9023642B2 (en) Method and apparatus for a miniature bioreactor system for long-term cell culture
WO2024027717A1 (en) Total system and method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microsphere
WO2020215488A1 (en) Method for high-throughput culture of organoid spheres
CN103257213B (en) A kind of fully integrated high-flux cell horizontal micro-fluidic chip drug evaluation system
US20210095235A1 (en) Fluidic array systems and testing for cells, organoids, and organ cultures
US20120009559A1 (en) Automated cell culture system and process
US20220333056A1 (en) System and method for creating tissue
CN106399094A (en) Cell culture and gradient migration assay methods and devices
CN112226363B (en) Device and method for culturing high-flux organoid by utilizing microarray deep well
CN108823145A (en) A kind of vitro construction method of human brain Angiogenesis simulation blood-brain barrier
CN114540305A (en) Preparation method of organoid structure based on microfluidic technology high-flux culture
EP3535383B1 (en) Method for creating tissue
JP2021513363A (en) Perfutable bioreactor
CN108641931A (en) A kind of digitlization microarray organ chip and its application
CN208762505U (en) A kind of digitlization microarray organ chip
CN116103148A (en) Preparation system and preparation method of core-shell structure external organ microsphere and total system
KR20210005606A (en) System and method for multi-lane vasculature
EP2970854B1 (en) Rotational dual chamber bioreactor: methods and uses thereof
WO2024026676A1 (en) Preparation system and preparation method for vitroorganospheres with core-shell structure, and total system
CN105754856B (en) A kind of drawer type three-dimensional class blood vessel tissue culture organ chip and its construction method
TW202235842A (en) Micro-organospheres for use in personalized medicine and drug development
Yu et al. Vascularized organoid-on-a-chip: design, imaging, and analysis
JP2020516286A (en) An array of live cells that have been vascularized in vitro
US12024701B2 (en) System and method for creating tissue

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23849423

Country of ref document: EP

Kind code of ref document: A1